{
    "title": "Vitamin D associations with erectile dysfunction",
    "slug": "vitamin-d-associations-with-erectile-dysfunction",
    "aliases": [
        "/Vitamin+D+associations+with+erectile+dysfunction+-+April+2012",
        "/2638"
    ],
    "tiki_page_id": 2638,
    "date": "2012-04-25",
    "categories": [
        "Fertility and sperm"
    ],
    "tags": [
        "CKD",
        "Fertility and sperm",
        "asthma",
        "asthma receptor",
        "atherosclerosis",
        "atopic dermatitis",
        "autoimmune",
        "bacteria",
        "blood levels",
        "bone",
        "bone cancer",
        "brain",
        "breathing",
        "cancer",
        "cancer in VDR",
        "cardiovascular",
        "child",
        "childhood cancer",
        "childhood obesity",
        "childhood respiratory",
        "childhood viruses",
        "cholesterol",
        "cognitive",
        "dementia",
        "depression",
        "dermatology",
        "diabetes",
        "diabetes and vitamin d receptor",
        "dosage",
        "epilepsy",
        "falls fractures",
        "genetics",
        "health risk",
        "heart failure",
        "hemodialysis",
        "high dose",
        "hypertension",
        "intervention",
        "kidney",
        "life span",
        "metabolic",
        "metabolic conditions",
        "metabolic syndrome",
        "mood disorders",
        "mortality",
        "multiple sclerosis",
        "neurological",
        "obesity",
        "obesity and cancer",
        "obesity and vitamin d receptor",
        "omega 3",
        "omega 3 and viruses",
        "pain",
        "pediatric autoimmune",
        "psoriasis",
        "respiratory",
        "rheumatoid arthritis",
        "smoking",
        "statins",
        "stroke",
        "stroke and depression",
        "therapeutic intervention",
        "tuberculosis",
        "ultraviolet light",
        "virus",
        "virus and cardiovascular",
        "virus and cognitive",
        "virus and obesity",
        "viruses and vitamin d receptor",
        "vitamin d",
        "vitamin d and viruses",
        "vitamin d blood test",
        "vitamin d receptor"
    ]
}


Rough copy from [/dermatoendocrinology](http://www.landesbioscience.com/journals/dermatoendocrinology/article/20361/?show_full_text=true)

scroll down to see the actual paper

<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">

<!-- saved from url=(0096)http://www.landesbioscience.com/journals/dermatoendocrinology/article/20361/?show_full_text=true -->

<html xmlns="http://www.w3.org/1999/xhtml" xml:lang="en" lang="en"><head><meta http-equiv="Content-Type" content="text/html; charset=UTF-8">

<script type="text/javascript">var NREUMQ=NREUMQ||[];NREUMQ.push(["mark","firstbyte",new Date().getTime()]);</script>

<b>Landes Bioscience Journals: Dermato-Endocrinology</b>

<link rel="stylesheet" type="text/css" media="screen, projection" href="./dertmato 7_files/screen.v1240858290.css">

<link rel="stylesheet" type="text/css" media="screen, projection" href="./dertmato 7_files/screen.v1238959200.css">

<link rel="stylesheet" type="text/css" media="screen, projection" href="./dertmato 7_files/base.v1299870894.css">

<link rel="stylesheet" type="text/css" media="screen, projection" href="./dertmato 7_files/main_style.v1317147690.css">

<link rel="stylesheet" type="text/css" media="screen, projection" href="./dertmato 7_files/jquery-ui-1.8.1.custom.v1291582501.css">

<link rel="stylesheet" type="text/css" media="screen, projection" href="./dertmato 7_files/superfish.v1233794143.css">

<link rel="stylesheet" type="text/css" media="screen, projection" href="./dertmato 7_files/generated_style.v1310666403.css">

<link rel="stylesheet" type="text/css" media="screen, projection" href="./dertmato 7_files/user_journal_edboard.v1248984687.css">

<link rel="stylesheet" type="text/css" media="screen, projection" href="./dertmato 7_files/prettyPhoto.v1291582683.css">

<link rel="stylesheet" type="text/css" media="screen, projection" href="./dertmato 7_files/disqus_hide_post_box.v1296153969.css">

<link rel="stylesheet" type="text/css" media="screen, projection" href="./dertmato 7_files/user_journal.v1330718755.css">

<link rel="stylesheet" type="text/css" media="screen, projection" href="./dertmato 7_files/thickbox.v1233793846.css">

<link rel="stylesheet" type="text/css" media="print" href="./dertmato 7_files/print.v1301688685.css">

<!--[if IE]><link rel="stylesheet" type="text/css" media="screen, projection" href="/css/blueprint/ie.v1238959200.css"/><![endif]-->

<!--[if IE]><link rel="stylesheet" type="text/css" media="screen, projection" href="/css/ie_main_style.v1301587202.css"/><![endif]-->

<link rel="icon" href="http://www.landesbioscience.com/images/favicon.ico" type="image/x-icon">

<link rel="shortcut icon" href="http://www.landesbioscience.com/images/favicon.ico" type="image/x-icon">

<script type="text/javascript">

var gaJsHost = (("https:" == document.location.protocol) ? "https://ssl." : "http://www.");

document.write(unescape("%3Cscript src='" + gaJsHost + "google-analytics.com/ga.js' type='text/javascript'%3E%3C/script%3E"));

</script><script src="./dertmato 7_files/ga.js" type="text/javascript"></script>

<script type="text/javascript">

try {

var pageTracker = _gat._getTracker("UA-11960531-1");

pageTracker._setDomainName(".landesbioscience.com");

pageTracker._trackPageview();

} catch(err) {}</script>

<script type="text/javascript" src="./dertmato 7_files/jquery-1.4.2.min.v1291582749.js"></script>

<script type="text/javascript" src="./dertmato 7_files/jquery-ui-1.8.1.custom.min.v1291582504.js"></script>

<script type="text/javascript" src="./dertmato 7_files/jquery.livequery.v1233793846.js"></script>

<script type="text/javascript" src="./dertmato 7_files/hoverIntent.v1233794143.js"></script>

<script type="text/javascript" src="./dertmato 7_files/supersubs.v1233794143.js"></script>

<script type="text/javascript" src="./dertmato 7_files/jquery.bgiframe.min.v1233794143.js"></script>

<script type="text/javascript" src="./dertmato 7_files/superfish.v1233794143.js"></script>

<script type="text/javascript" src="./dertmato 7_files/site2.v1314294747.js"></script>

<script type="text/javascript" src="./dertmato 7_files/jquery.prettyPhoto.v1291582683.js"></script>

<script type="text/javascript" src="./dertmato 7_files/thickbox.v1233793846.js"></script>

<script type="text/javascript" src="./dertmato 7_files/jquery.throbber.v1233793848.js"></script>

<script type="text/javascript" src="./dertmato 7_files/jquery.selectboxes.v1233793848.js"></script>

<script type="text/javascript" src="./dertmato 7_files/rotator.v1249330610.js"></script>

<script type="text/javascript" src="./dertmato 7_files/jquery.uri.v1233794143.js"></script>

<script type="text/javascript" src="./dertmato 7_files/user_journals.v1334685394.js"></script>

</head><link rel="stylesheet" type="text/css" href="data:text/css,">

<body style="width: 1250px; ">

<div id="landes_page">

<div class="container ">

<div class=" span-24">

<div class="landes_masthead span-24">

<div class="span-3"><a href="http://www.landesbioscience.com/"><img id="landes_logo" src="./dertmato 7_files/landes_logo_medium.gif"></a></div>

<div class=" span-17 ">

<div id="landes_masthead_north" class="" style="height:91px; ">

<div id="landes_masthead_north_logo"></div>

</div>

<div id="landes_masthead_center">

<div id="landes_main_nav" class="landes_top_nav landes_top_nav_color">

<ul class="landes_main_menu sf-js-enabled">

<li class="first"><a href="http://www.landesbioscience.com/">Home</a></li>

<li><a href="http://www.landesbioscience.com/journals/" id="landes_main_nav_journals">Journals</a>

<ul style="width: 470px; padding-top: 5px; padding-right: 0px; padding-bottom: 5px; padding-left: 0px; display: none; visibility: hidden; ">

<div style="float:left !important; border-right:1px solid #C6D0CE; padding-right:10px;">

</div>

<div style="float:left !important;">

</div>

</ul>

</li>

<li><a href="http://www.landesbioscience.com/journals/dermatoendocrinology/article/20361/?show_full_text=true#" id="landes_main_nav_books">Books</a>

<ul style="padding-top: 5px; padding-right: 0px; padding-bottom: 5px; padding-left: 0px; display: none; visibility: hidden; ">

<li><a href="http://www.landesbioscience.com/books/iu/">Intelligence Unit</a></li>

<li><a href="http://www.landesbioscience.com/books/special/">Special Books</a></li>

<li><a href="http://www.landesbioscience.com/books/vademecum/">Vademecum Medical Handbooks</a></li>

</ul>

</li>

<li><a href="http://www.landesbioscience.com/curie/">Madame Curie Database</a></li>

<li><a href="http://www.landesbioscience.com/contact/">Contact</a></li>

<li><a href="http://www.landesbioscience.com/support/request/">Support</a></li>

<li><a href="http://www.landesbioscience.com/journals/libraries/">For Librarians</a></li>

<li><a href="http://www.landesbioscience.com/ipad/about/">iPad</a></li>

</ul>

</div>

</div>

</div>

<div class="span-4 last">

<div id="landes_masthead_east">

<div id="landes_login_nav" class="pull-4 span-8 last">

<ul>

<li><a href="http://www.landesbioscience.com/login/">Login</a></li>

</ul>

<br>

<ul>

</ul>

</div>

<div id="landes_search_nav" class="span-5 last">

</div>

</div>

</div>

</div>

<div id="landes_masthead_south" class="span-24">

<div id="landes_sub_nav" class=" j_subnav">

<ul class="landes_sub_menu">

</div>

</div>

<div class="landes_content span-24 ">

<div class=" span-20 prepend-top append-bottom">

<div class="landes_content_center"><h4 class="shorter">Review</h4>

<h2 id="article_title" class="j_color1 shorter">Does vitamin D deficiency contribute to erectile dysfunction?</h2>

<div class="span-13 append-1">

<a id="issue_url" href="http://www.landesbioscience.com/journals/dermatoendocrinology/toc/volume/4/issue/2/">

Volume 4, Issue 2</a>&nbsp;&nbsp;&nbsp;April/May 2012<br>

<b>Keywords</b>: calcification, diabetes, erectile dysfunction, hypertension, inflammation, nitric oxide, peripheral arterial disease, vascular diseases, vasodilation, Vitamin D<br>

<h5 id="author_commalist" class="shorter " style="font-weight:normal; display:inline;"><b>Authors</b>: Marc Sorenson and William B. Grant</h5> <br><a href="http://www.landesbioscience.com/journals/dermatoendocrinology/article/20361/?show_full_text=true#" class="author_toggle">View affiliations</a> <a href="http://www.landesbioscience.com/journals/dermatoendocrinology/article/20361/?show_full_text=true#" class="author_toggle" style="display:none;">Hide affiliations</a>

<dl id="author_fulllist" style="display:none;">

<dt>Marc Sorenson</dt>

<dd>

Corresponding author: <a href="mailto:megamarc1@aol.com">megamarc1@aol.com</a><br>

Sunlight Institute; Saint George, UT USA

</dd>

<dt>William B. Grant</dt>

<dd>

Sunlight, Nutrition, and Health Research Center; San Francisco, CA USA

</dd>

</dl>

<br><br>

<p id="abstract">

Erectile dysfunction (ED) is a multifactorial disease, and its causes can be neurogenic, psychogenic, hormonal and vascular. ED is often an important indicator of cardiovascular disease (CVD) and a powerful early marker for asymptomatic CVD. Erection is a vascular event, and ED is often a vascular disease caused by endothelial damage and subsequent inhibition of vasodilation. We show here that risk factors associated with a higher CVD risk also associate with a higher ED risk. Such factors include diabetes mellitus, hypertension, arterial calcification and Inflammation in the vascular endothelium. Vitamin D deficiency is one of several dynamics that associates with increased CVD risk, but to our knowledge, it has not been studied as a possible contributor to ED. Here we examine research linking ED and CVD and discuss how vitamin D influences CVD and its classic risk factors—factors that also associate to increased ED risk. We also summarize research indicating that vitamin D associates with reduced risk of several nonvascular contributing factors for ED. We conclude that VDD contributes to ED. This hypothesis should be tested through observational and intervention studies.

</p>

</div>

<div id="links_box" class="span-6 last">

<h4 class="large shorter"><img src="./dertmato 7_files/download.png" style="position:relative; top:6px;"> Purchase or Subscribe</h4>

<div style="background:#f2faf8;border:1px solid #DDD; padding:18px 12px;">

The pdf of this article is not yet available for download. Check back soon.<br><br>

<a href="http://www.landesbioscience.com/journals/dermatoendocrinology/subscribe/">Subscribe to <i>Dermato-Endocrinology</i></a>

<br><br>

<a href="http://www.landesbioscience.com/recommend/">Recommend this Publication</a>

<br><br>

<a href="http://www.landesbioscience.com/login/">Subscriber Login</a>

<br><br>

<hr>

<a href="http://www.facebook.com/sharer.php?u=http%3A%2F%2Fwww.landesbioscience.com%2Fjournals%2Fdermatoendocrinology%2Farticle%2F20361%2F%3Fshow_full_text%3Dtrue" target="_blank" style="display:block; margin-bottom:5px;"><img src="./dertmato 7_files/facebook_24.png" style="position:relative; top:7px;"> Share on Facebook</a>

<br>

<a href="http://www.linkedin.com/shareArticle?mini=true&url=http%3A%2F%2Fwww.landesbioscience.com%2Fjournals%2Fdermatoendocrinology%2Farticle%2F20361%2F&title=Does+vitamin+D+deficiency+contribute+to+erectile+dysfunction%3F&summary=Erectile%20dysfunction%20(ED)%20is%20a%20multifactorial%20disease,%20and%20its%20causes%20can%20be%20neurogenic,%20psychogenic,%20hormonal%20and%20vascular.%20ED%20is%20often%20an%20important%20indicator%20of%20cardiovascular%20disease%20(CVD)%20and%20a" target="_blank"><img src="./dertmato 7_files/linkedin.png"></a>

<br><br>

<a href="https://twitter.com/share?url=http://www.landesbioscience.com/journals/dermatoendocrinology/article/20361/&text=Dermato-Endocrinology:%20Does%20vitamin%20D%20deficiency%20contribute%20to%20erectile%20dysfunction?" class="twitter-share-button"><img src="./dertmato 7_files/tweet_button.png"></a> 

</div>

</div>

<div style="margin:20px 0;width:100%;height:25px;background-color:#f2faf8;float:left;"><h3>Full Text  </h3></div>    

<input type="hidden" id="journal_short_name" value="dermatoendocrinology">

<div id="full_text" style="width: 760px; float: left; " align="justify"><img src="./dertmato 7_files/delete.png" style="display:inline;" role=".section_1"><h4 class="section_title" style="color: rgb(101, 77, 62); "><b>Introduction: Important facts pertaining to this discussion</b></h4><br><br><div class="section_1">

<p xmlns:oasis="http://docs.oasis-open.org/ns/oasis-exchange/table">Vitamin D is a steroid hormone produced in human skin by sunlight stimulation, specifically the UV-B (UVB) portion of the sunlight spectrum; about 80% of vitamin D is thus obtained.<xref ref-type="bibr" rid="R1" style="cursor: pointer; color: rgb(128, 64, 0); font-weight: bold; "><sup>1</sup></xref> The angle of sunlight varies greatly by season. In summer, the sun is overhead at noon, but in winter it stays closer to the horizon, and sunlight must pass through more atmosphere, which filters out much or all of the UVB. Therefore, availability of UVB exposure, and its resultant vitamin D production in skin, is highest in late spring through early fall and lowest from late fall through early spring. Consequently, vitamin D levels in the bloodstream also vary by season, with levels highest in late spring through early fall and lowest from late fall through early spring. For example, vitamin D levels in the UK are about 50% higher at the end of summer than at the end of winter.<xref ref-type="bibr" rid="R1" style="cursor: pointer; color: rgb(128, 64, 0); font-weight: bold; "><sup>1</sup></xref></p>

<p xmlns:oasis="http://docs.oasis-open.org/ns/oasis-exchange/table">Vitamin D deficiency (VDD) has increased profoundly in the last two decades. According to data from the National Health and Nutrition Examination Survey (NHANES), 45% of the US population had serum vitamin D levels of 30 ng/mL (considered adequate for health<xref ref-type="bibr" rid="R2" style="cursor: pointer; color: rgb(128, 64, 0); font-weight: bold; "><sup>2</sup></xref>) in 1998–1994, whereas in 2001–2004, this figure was only 23%, a drop of 49%.<xref ref-type="bibr" rid="R3" style="cursor: pointer; color: rgb(128, 64, 0); font-weight: bold; "><sup>3</sup></xref> Concomitantly, the incidence of erectile dysfunction (ED) is rising: worldwide, the number of men with ED will increase from 150 million in 1995 to an estimated 322 million in 2025.<xref ref-type="bibr" rid="R4" style="cursor: pointer; color: rgb(128, 64, 0); font-weight: bold; "><sup>4</sup></xref> ED is also prevalent in the US, affecting approximately 18–30 million men older than 20 y.<xref ref-type="bibr" rid="R5" style="cursor: pointer; color: rgb(128, 64, 0); font-weight: bold; "><sup>5</sup></xref><sup>,</sup><xref ref-type="bibr" rid="R6" style="cursor: pointer; color: rgb(128, 64, 0); font-weight: bold; "><sup>6</sup></xref> Much of the worldwide upsurge may be due to an aging population, a deteriorating diet, lack of exercise, and other unhealthful practices.</p>

<p xmlns:oasis="http://docs.oasis-open.org/ns/oasis-exchange/table">One recent study found risk of ED associated with “body mass index (BMI), irritative lower urinary tract symptoms, diabetes mellitus, chronic obstructive pulmonary disease (COPD) and sexual inactivity.”<xref ref-type="bibr" rid="R7" style="cursor: pointer; color: rgb(128, 64, 0); font-weight: bold; "><sup>7</sup></xref></p>

<p xmlns:oasis="http://docs.oasis-open.org/ns/oasis-exchange/table">“Most cases [of ED] have a multifactorial origin and it is admitted the influence on its pathogenesis of systemic diseases, different kind of drugs, psychogenic factors, cardiovascular, endocrinological and neurological diseases. Neurologic causes of erectile dysfunction may have their origins in the central or peripheral nervous system. Among possible process of neurogenic erectile dysfunction of central origin would be tumors, cerebral vascular accidents, encephalitis, Parkinson disease, multiple sclerosis and other demyelinization diseases, dementias, olivopontocerebellar degeneration and epilepsy.”<xref ref-type="bibr" rid="R8" style="cursor: pointer; color: rgb(128, 64, 0); font-weight: bold; "><sup>8</sup></xref></p>

<p xmlns:oasis="http://docs.oasis-open.org/ns/oasis-exchange/table">It has been estimated that about half of ED is related to vascular causes.<xref ref-type="bibr" rid="R9" style="cursor: pointer; color: rgb(128, 64, 0); font-weight: bold; "><sup>9</sup></xref> VDD also contributes to ED apart from its negative influence on classic CVD risk factors.</p>

</div><img src="./dertmato 7_files/delete.png" style="display:inline;" role=".section_2"><h4 class="section_title" style="color: rgb(101, 77, 62); "><b>The role of vascular disorders in ED</b></h4><br><br><div class="section_2">

<p xmlns:oasis="http://docs.oasis-open.org/ns/oasis-exchange/table">ED is an inability to produce an erection sufficiently rigid for sexual intercourse. ED incidence increases with age; the most severe form (defined as never being able to achieve an erection) occurs in 2% of men aged 20–39 y, increasing to 47% of men aged 75 y.<xref ref-type="bibr" rid="R10" style="cursor: pointer; color: rgb(128, 64, 0); font-weight: bold; "><sup>10</sup></xref></p>

<p xmlns:oasis="http://docs.oasis-open.org/ns/oasis-exchange/table">The penis is a highly vascularized organ, and erections are primarily vascular events.<xref ref-type="bibr" rid="R11" style="cursor: pointer; color: rgb(128, 64, 0); font-weight: bold; "><sup>11</sup></xref> Sexual stimulation causes the release of neurotransmitters from the corpus cavernosa (the two cylindrical chambers that run the length of the penis) and a relaxing factor, now established as nitric oxide (NO), from the endothelial cells of the penis.<xref ref-type="bibr" rid="R12" style="cursor: pointer; color: rgb(128, 64, 0); font-weight: bold; "><sup>12</sup></xref> NO is particularly important; vasodilation is essential to erection, and NO is the trigger for vasodilation in the vascular endothelium.<xref ref-type="bibr" rid="R13" style="cursor: pointer; color: rgb(128, 64, 0); font-weight: bold; "><sup>13</sup></xref><sup>,</sup><xref ref-type="bibr" rid="R14" style="cursor: pointer; color: rgb(128, 64, 0); font-weight: bold; "><sup>14</sup></xref> The neurotransmitters, together with NO, cause the corpus cavernosa to relax and allow blood to flow into the penis, causing the penis to expand and sustain an erection until the process is reversed.<xref ref-type="bibr" rid="R15" style="cursor: pointer; color: rgb(128, 64, 0); font-weight: bold; "><sup>15</sup></xref> Any disorder causing endothelial dysfunction (END) will also interfere with vasodilation, which prevents erection. END is an early marker for the development of atherosclerosis.<xref ref-type="bibr" rid="R16" style="cursor: pointer; color: rgb(128, 64, 0); font-weight: bold; "><sup>16</sup></xref> In fact, END is the key factor in the pathophysiology of ED, and men with penile END also have END in other blood vessels.<xref ref-type="bibr" rid="R17" style="cursor: pointer; color: rgb(128, 64, 0); font-weight: bold; "><sup>17</sup></xref></p>

<p xmlns:oasis="http://docs.oasis-open.org/ns/oasis-exchange/table">The increase in the number of patients with CVD risk factors parallels the worldwide increase in ED prevalence,<xref ref-type="bibr" rid="R18" style="cursor: pointer; color: rgb(128, 64, 0); font-weight: bold; "><sup>18</sup></xref> which one would expect given that the two disorders result from intertwined disease processes.<xref ref-type="bibr" rid="R19" style="cursor: pointer; color: rgb(128, 64, 0); font-weight: bold; "><sup>19</sup></xref> Although nonvascular factors such as depression, fatigue, stress, Parkinson disease, multiple sclerosis (MS), and hypertensive medications may affect ED,<xref ref-type="bibr" rid="R12" style="cursor: pointer; color: rgb(128, 64, 0); font-weight: bold; "><sup>12</sup></xref> it is primarily a vasculogenic disease. Its most prevalent cause is the arterial occlusion of atherosclerosis, which also affects the coronary arteries and can lead to heart attack<xref ref-type="bibr" rid="R11" style="cursor: pointer; color: rgb(128, 64, 0); font-weight: bold; "><sup>11</sup></xref> or, in other parts of the body, vascular events such as stroke<xref ref-type="bibr" rid="R20" style="cursor: pointer; color: rgb(128, 64, 0); font-weight: bold; "><sup>20</sup></xref> and peripheral arterial disease (PAD).<xref ref-type="bibr" rid="R21" style="cursor: pointer; color: rgb(128, 64, 0); font-weight: bold; "><sup>21</sup></xref></p>

<p xmlns:oasis="http://docs.oasis-open.org/ns/oasis-exchange/table">Because the penile arteries are smaller than arteries supplying other areas of the body, the first symptoms of atherosclerosis may manifest as ED, making ED one of the best predictors of CVD.13<sup>,22,23,24,25</sup> Coronary artery disease is a CVD that is highly predictable by the presence of ED. Jackson and colleagues have stated that after the onset of ED, many men experience CVD symptoms in 2–3 y and then suffer cardiovascular events (such as heart attack or stroke) in 3–5 y.<xref ref-type="bibr" rid="R26" style="cursor: pointer; color: rgb(128, 64, 0); font-weight: bold; "><sup>26</sup></xref> One CVD, PAD, is also associated with the presence of ED. ED is an independent predictor of PAD, and increasing severity of ED is associated with increasing prevalence of PAD.<xref ref-type="bibr" rid="R27" style="cursor: pointer; color: rgb(128, 64, 0); font-weight: bold; "><sup>27</sup></xref></p>

<p xmlns:oasis="http://docs.oasis-open.org/ns/oasis-exchange/table">Bohm and colleagues, after conducting a 2 y, randomized, controlled trial to determine whether ED was a harbinger of CVD events, demonstrated that ED was a potent predictor of myocardial infarction, stroke, and heart failure in men with preexisting CVD. ED also predicted an increased hazard ratio of 1.84 (95% confidence interval, 1.21–2.81; p = 0.005) for all-cause death.<xref ref-type="bibr" rid="R28" style="cursor: pointer; color: rgb(128, 64, 0); font-weight: bold; "><sup>28</sup></xref> In discussing the results of this study and the danger that ED drugs (phosphodiesterase-5 inhibitors) might pose by causing ED patients to ignore the presence of CVD, Bohm observed the following: “The drug works and the patient doesn’t show up anymore. These men are being treated for ED, but not the underlying cardiovascular disease. A whole segment of men is being placed at risk.”<xref ref-type="bibr" rid="R29" style="cursor: pointer; color: rgb(128, 64, 0); font-weight: bold; "><sup>29</sup></xref> Other researchers have concluded that the presence of ED should trigger an aggressive assessment for occult vascular disease.<xref ref-type="bibr" rid="R11" style="cursor: pointer; color: rgb(128, 64, 0); font-weight: bold; "><sup>11</sup></xref></p>

<p xmlns:oasis="http://docs.oasis-open.org/ns/oasis-exchange/table">Because both CVD and ED are, at least in part, vascular diseases, and ED is a potent predictor of CVD, the presence of risk factors for CVD also predicts the presence of ED,<xref ref-type="bibr" rid="R30" style="cursor: pointer; color: rgb(128, 64, 0); font-weight: bold; "><sup>30</sup></xref> and treatments that improve CVD often also do so for ED. Treatments with lifestyle changes, for example, are quite effective. Gupta and colleagues performed a meta-analysis of randomized, controlled clinical trials and demonstrated that with lifestyle modification and CVD risk-factor reduction programs in men with ED, sexual function increased by 2.4 times with lifestyle changes alone and by 2.66 times when statin therapy was included.<xref ref-type="bibr" rid="R31" style="cursor: pointer; color: rgb(128, 64, 0); font-weight: bold; "><sup>31</sup></xref> One effect of some statins is an increase in serum 25(OH)D concentrations<xref ref-type="bibr" rid="R32" style="cursor: pointer; color: rgb(128, 64, 0); font-weight: bold; "><sup>32</sup></xref></p>

<p xmlns:oasis="http://docs.oasis-open.org/ns/oasis-exchange/table">One effective lifestyle change included a diet rich in whole grains, fruits, vegetables, legumes, walnuts, and olive oil; another was an exercise program (running or vigorous outdoor activity). Optimizing vitamin D levels through sunlight exposure or supplementation was not part of the lifestyle changes, but it should have been: VDD is associated with arterial stiffness and vascular dysfunction.<xref ref-type="bibr" rid="R33" style="cursor: pointer; color: rgb(128, 64, 0); font-weight: bold; "><sup>33</sup></xref><sup>,</sup><xref ref-type="bibr" rid="R34" style="cursor: pointer; color: rgb(128, 64, 0); font-weight: bold; "><sup>34</sup></xref> Vasculogenic ED results from impaired smooth-muscle relaxation (endothelial-dependent-or-independent), occlusion of the cavernosal arteries by atherosclerosis, or both.<xref ref-type="bibr" rid="R17" style="cursor: pointer; color: rgb(128, 64, 0); font-weight: bold; "><sup>17</sup></xref></p>

</div><img src="./dertmato 7_files/delete.png" style="display:inline;" role=".section_3"><h4 class="section_title" style="color: rgb(101, 77, 62); "><b>The role of vitamin D and sunlight on CVD</b></h4><br><br><div class="section_3">

<p xmlns:oasis="http://docs.oasis-open.org/ns/oasis-exchange/table">VDD is rampant among heart disease patients; University of Kansas researchers found that 70.3% of their heart disease patients had serum vitamin D levels below 30 ng/mL (the measure considered adequate for health) and that supplemental vitamin D was associated with a 61% reduction in the risk of death.<xref ref-type="bibr" rid="R35" style="cursor: pointer; color: rgb(128, 64, 0); font-weight: bold; "><sup>35</sup></xref> Giovannucci and colleagues showed that men with the lowest levels of serum vitamin D had a 2.4-times-increased risk of heart attack.<xref ref-type="bibr" rid="R36" style="cursor: pointer; color: rgb(128, 64, 0); font-weight: bold; "><sup>36</sup></xref></p>

</div><img src="./dertmato 7_files/delete.png" style="display:inline;" role=".section_4"><h4 class="section_title" style="color: rgb(101, 77, 62); "><b>Possible influence of sunlight or vitamin D on four major risk factors for CVD and ED</b></h4><br><br><div class="section_4">

<p xmlns:oasis="http://docs.oasis-open.org/ns/oasis-exchange/table">We hypothesize that optimizing vitamin D levels in men with ED could achieve similar positive influences on that disease. We first discuss four classic risk factors for CVD and ED and present research suggesting the influence of sunlight or vitamin D on each factor. We then briefly discuss other influences of vitamin D on ED that have not been thoroughly covered in conjunction with the four common risk factors discussed.</p>

<sec xmlns:oasis="http://docs.oasis-open.org/ns/oasis-exchange/table">

<b>Arterial calcification</b>

<p>Arterial calcification is a common feature of atherosclerosis, occurring in more than 90% of angiographically significant lesions.<xref ref-type="bibr" rid="R37" style="cursor: pointer; color: rgb(128, 64, 0); font-weight: bold; "><sup>37</sup></xref> Measures of arterial calcification have been used since 1964 to predict myocardial infarct,<xref ref-type="bibr" rid="R38" style="cursor: pointer; color: rgb(128, 64, 0); font-weight: bold; "><sup>38</sup></xref> and in 1990, 83–90% of CVD patients showed calcification of their coronary arteries—a far higher percentage than disease-free people.<xref ref-type="bibr" rid="R39" style="cursor: pointer; color: rgb(128, 64, 0); font-weight: bold; "><sup>39</sup></xref> Arterial calcification remains a strong marker of increased risk of CVD,<xref ref-type="bibr" rid="R40" style="cursor: pointer; color: rgb(128, 64, 0); font-weight: bold; "><sup>40</sup></xref><sup>,</sup><xref ref-type="bibr" rid="R41" style="cursor: pointer; color: rgb(128, 64, 0); font-weight: bold; "><sup>41</sup></xref> independent of other known risk factors.<xref ref-type="bibr" rid="R42" style="cursor: pointer; color: rgb(128, 64, 0); font-weight: bold; "><sup>42</sup></xref><sup>,</sup><xref ref-type="bibr" rid="R43" style="cursor: pointer; color: rgb(128, 64, 0); font-weight: bold; "><sup>43</sup></xref></p>

<p>Arterial calcification is also a risk factor for ED. Lee and colleagues demonstrated that men who had ED were about 40% more likely to have measurable coronary artery calcification than those without ED.<xref ref-type="bibr" rid="R44" style="cursor: pointer; color: rgb(128, 64, 0); font-weight: bold; "><sup>44</sup></xref> They concluded that ED “is significantly associated with abnormal coronary artery calcification and, like PAD, might warrant consideration as a coronary artery disease risk equivalent.”</p>

<p>Serum vitamin D levels and arterial calcification have a strong inverse relationship,<xref ref-type="bibr" rid="R37" style="cursor: pointer; color: rgb(128, 64, 0); font-weight: bold; "><sup>37</sup></xref> provided that vitamin D levels are not excessively high, which can exacerbate calcification. Zittermann and colleagues explain that vitamin D exerts a biphasic dose–response curve on vascular calcification with deleterious consequences not only for vitamin D excess but also for VDD. They also note, however, that vitamin D excess seldom occurs in the general population.<xref ref-type="bibr" rid="R45" style="cursor: pointer; color: rgb(128, 64, 0); font-weight: bold; "><sup>45</sup></xref> These researchers also mention that in rats, low levels of activated vitamin D (1,25-dihydroxyvitamin D or calcitriol) are associated with massive calcification of blood vessels and other soft tissues.</p>

<p>We hypothesize that optimizing vitamin D levels through sunlight exposure or supplementation would have positive benefits for those suffering from ED associated with vascular calcification.</p>

</sec><sec xmlns:oasis="http://docs.oasis-open.org/ns/oasis-exchange/table">

<b>Diabetes mellitus</b>

<p>Diabetes mellitus (DM) is a disorder of carbohydrate metabolism characterized by excessive glucose levels in urine due either to inadequate production of insulin (insulin-dependent, or type 1 DM) or to poor insulin utilization (adult-onset, or type-2 DM), both of which result in increased urine flow. Ninety percent to 95% of diabetes cases in the US are type2.<xref ref-type="bibr" rid="R46" style="cursor: pointer; color: rgb(128, 64, 0); font-weight: bold; "><sup>46</sup></xref> The presence of DM is a profound predictor of CVD, correlating to an increased risk of CVD of approximately 2.5 times.<xref ref-type="bibr" rid="R47" style="cursor: pointer; color: rgb(128, 64, 0); font-weight: bold; "><sup>47</sup></xref> Although incidence of CVD has decreased somewhat in the past few decades, it has done so only in those without DM. The incidence of DM rapidly increased from 1970 to 2000,<xref ref-type="bibr" rid="R48" style="cursor: pointer; color: rgb(128, 64, 0); font-weight: bold; "><sup>48</sup></xref> especially during the 1990s, and those with DM have shown a dramatic upsurge in the risk of CVD. For example, during the 1990s, the risk of acute myocardial infarction increased among those with DM by 51%, and general CVD rates in men with DM increased by 61%.<xref ref-type="bibr" rid="R49" style="cursor: pointer; color: rgb(128, 64, 0); font-weight: bold; "><sup>49</sup></xref> Diabetes leads to CVD by causing END, a precursor to atherosclerosis, as follows:<xref ref-type="bibr" rid="R50" style="cursor: pointer; color: rgb(128, 64, 0); font-weight: bold; "><sup>50</sup></xref> High levels of glucose in the blood inhibit the production of NO.<xref ref-type="bibr" rid="R51" style="cursor: pointer; color: rgb(128, 64, 0); font-weight: bold; "><sup>51</sup></xref> This inhibition impairs vasodilation of vessels and leads to atherosclerosis<xref ref-type="bibr" rid="R52" style="cursor: pointer; color: rgb(128, 64, 0); font-weight: bold; "><sup>52</sup></xref> by promoting vasoconstriction, hypertension, vascular smooth-muscle growth, inflammation, expression of cellular adhesion molecules (CAMs), platelet activation, decreased fibrinolysis, and thrombosis.<xref ref-type="bibr" rid="R53" style="cursor: pointer; color: rgb(128, 64, 0); font-weight: bold; "><sup>53</sup></xref> Both type 1 and type 2 DM follow this pattern. Awad and colleagues stated that “the diabetes control and complications trial clearly showed that better long-term control of blood glucose in diabetes type 1 is associated with decreased frequency and delayed the onset of microvascular complications.”<xref ref-type="bibr" rid="R54" style="cursor: pointer; color: rgb(128, 64, 0); font-weight: bold; "><sup>54</sup></xref> These changes in the vessel walls affect the brain as well as the heart: diabetics younger than 55 y have 11.6 times the risk of stroke.<xref ref-type="bibr" rid="R55" style="cursor: pointer; color: rgb(128, 64, 0); font-weight: bold; "><sup>55</sup></xref></p>

<p>DM also is associated closely with the risk of ED, as one would expect given how DM damages the vascular system. Reviewing the literature, Phe and Roupret concluded that “the pathophysiology is multifactorial, involving END, specific complications of diabetes and psychological factors.”<xref ref-type="bibr" rid="R56" style="cursor: pointer; color: rgb(128, 64, 0); font-weight: bold; "><sup>56</sup></xref> In fact, compared with nondiabetic men, men with DM have three to four times the risk of ED,<xref ref-type="bibr" rid="R57" style="cursor: pointer; color: rgb(128, 64, 0); font-weight: bold; "><sup>57</sup></xref><sup>,</sup><xref ref-type="bibr" rid="R58" style="cursor: pointer; color: rgb(128, 64, 0); font-weight: bold; "><sup>58</sup></xref> and the likelihood of ED in diabetic men ranges from 35–90%.<xref ref-type="bibr" rid="R59" style="cursor: pointer; color: rgb(128, 64, 0); font-weight: bold; "><sup>59</sup></xref> ED in men with diabetes also occurs 10–15 y earlier.<xref ref-type="bibr" rid="R60" style="cursor: pointer; color: rgb(128, 64, 0); font-weight: bold; "><sup>60</sup></xref></p>

<p>Sunlight exposure relates to DM. One paper showed that blood sugar levels are lower during summer than in winter,<xref ref-type="bibr" rid="R61" style="cursor: pointer; color: rgb(128, 64, 0); font-weight: bold; "><sup>61</sup></xref> and another showed that exposure to UVB light increases insulin secretion.<xref ref-type="bibr" rid="R62" style="cursor: pointer; color: rgb(128, 64, 0); font-weight: bold; "><sup>62</sup></xref></p>

<p>Vitamin D research indicates a close association between vitamin D and DM. Pittas and colleagues reported on research conducted on adults with impaired sugar tolerance and insulin resistance (both risk factors for diabetes). For 3 y, half received a placebo and the other half received vitamin D plus calcium. The rise in blood sugar levels was 15 times higher in the placebo group, and their increase in insulin resistance was 18 times higher.<xref ref-type="bibr" rid="R63" style="cursor: pointer; color: rgb(128, 64, 0); font-weight: bold; "><sup>63</sup></xref> Moreover, a 4-week program of high-dose vitamin D supplementation (10,000 IU daily) in subjects with impaired fasting glucose was associated with an improved insulin sensitivity and a decreased acute insulin response to glucose, both risk factors for DM.<xref ref-type="bibr" rid="R64" style="cursor: pointer; color: rgb(128, 64, 0); font-weight: bold; "><sup>64</sup></xref> Finally, a 16-week randomized, placebo-controlled study demonstrated that subjects who took 2,000 IU of vitamin D<sub>3</sub> daily had increased ?-cell function, as shown by a 37% improvement in insulin secretion.<xref ref-type="bibr" rid="R65" style="cursor: pointer; color: rgb(128, 64, 0); font-weight: bold; "><sup>65</sup></xref></p>

<p>We hypothesize that vitamin D optimization through sunlight exposure and/or vitamin D<sub>3</sub> supplementation would decrease END and subsequent vascular damage caused by diabetes and would reduce the risk of ED.</p>

</sec><sec xmlns:oasis="http://docs.oasis-open.org/ns/oasis-exchange/table">

<b>Hypertension and stroke</b>

<p>High blood pressure, or hypertension, especially systolic pressure, is a vascular disorder that is a potent predictor of CVD,<xref ref-type="bibr" rid="R66" style="cursor: pointer; color: rgb(128, 64, 0); font-weight: bold; "><sup>66</sup></xref> and a strong, linear, and independent relationship exists between the two.<xref ref-type="bibr" rid="R67" style="cursor: pointer; color: rgb(128, 64, 0); font-weight: bold; "><sup>67</sup></xref> Hypertension is also one of the most important risk factors for stroke.<xref ref-type="bibr" rid="R68" style="cursor: pointer; color: rgb(128, 64, 0); font-weight: bold; "><sup>68</sup></xref><sup>,</sup><xref ref-type="bibr" rid="R69" style="cursor: pointer; color: rgb(128, 64, 0); font-weight: bold; "><sup>69</sup></xref> Hypertension leads to END, which is mediated by impaired NO availability after oxidative stress.<xref ref-type="bibr" rid="R16" style="cursor: pointer; color: rgb(128, 64, 0); font-weight: bold; "><sup>16</sup></xref></p>

<p>Hypertension is also a risk factor for ED,<xref ref-type="bibr" rid="R70" style="cursor: pointer; color: rgb(128, 64, 0); font-weight: bold; "><sup>70</sup></xref> which afflicts to some degree 68% of men with hypertension.<xref ref-type="bibr" rid="R71" style="cursor: pointer; color: rgb(128, 64, 0); font-weight: bold; "><sup>71</sup></xref><sup>,</sup><xref ref-type="bibr" rid="R72" style="cursor: pointer; color: rgb(128, 64, 0); font-weight: bold; "><sup>72</sup></xref> Because hypertension leads to vascular damage and END, one would expect this outcome. The hypertension–ED–stroke connection is clear in the fact that over a 5-y period, men with ED have a 29% higher risk of stroke than those without ED.<xref ref-type="bibr" rid="R73" style="cursor: pointer; color: rgb(128, 64, 0); font-weight: bold; "><sup>73</sup></xref></p>

<p>The control of renin and angiotensin also affects hypertension. Renin is an enzyme that profoundly raises blood pressure by activating the peptide angiotensin, a vasoconstrictor.<xref ref-type="bibr" rid="R74" style="cursor: pointer; color: rgb(128, 64, 0); font-weight: bold; "><sup>74</sup></xref> Vitamin D may suppress hypertension by modulating the renin–angiotensin system,<xref ref-type="bibr" rid="R75" style="cursor: pointer; color: rgb(128, 64, 0); font-weight: bold; "><sup>75</sup></xref><sup>,</sup><xref ref-type="bibr" rid="R76" style="cursor: pointer; color: rgb(128, 64, 0); font-weight: bold; "><sup>76</sup></xref> a regulatory cascade essential in regulating blood pressure.<xref ref-type="bibr" rid="R77" style="cursor: pointer; color: rgb(128, 64, 0); font-weight: bold; "><sup>77</sup></xref> Vitamin D is a potent endocrine suppressor of renin biosynthesis, and VDD stimulates renin expression in normal mice.<xref ref-type="bibr" rid="R75" style="cursor: pointer; color: rgb(128, 64, 0); font-weight: bold; "><sup>75</sup></xref> Also, mice lacking vitamin D receptors produce more renin and angiotensin, leading to hypertension.<xref ref-type="bibr" rid="R77" style="cursor: pointer; color: rgb(128, 64, 0); font-weight: bold; "><sup>77</sup></xref></p>

<p>A direct relationship exists among hypertension, sunlight exposure, and stroke; the incidence of hypertension is considerably higher in winter than summer. One study of elderly hypertensive subjects showed that blood pressure levels averaged 165/90 in winter but 134/74 in the summer, and both stroke and heart attack rates doubled in winter.<xref ref-type="bibr" rid="R78" style="cursor: pointer; color: rgb(128, 64, 0); font-weight: bold; "><sup>78</sup></xref> Hypertension also follows the same pattern in children.<xref ref-type="bibr" rid="R79" style="cursor: pointer; color: rgb(128, 64, 0); font-weight: bold; "><sup>79</sup></xref> UVB light from sun lamps also effectively treats hypertension. In subjects who participated in three sessions per week of whole-body UVB exposure, vitamin D levels rose 162% after 6 weeks, and blood pressure dropped six points on both systolic and diastolic measurements.<xref ref-type="bibr" rid="R80" style="cursor: pointer; color: rgb(128, 64, 0); font-weight: bold; "><sup>80</sup></xref></p>

<p>Sunlight exposure’s ability to lower blood pressure may also be due to another spectrum of UV light—UVA. Opländer and colleagues demonstrated that whole-body irradiation with UVA lowered systemic blood pressure by stimulating NO production, significantly increasing intradermal levels of NO. These increased NO levels were accompanied by increased flow-mediated vasodilation of the brachial artery.<xref ref-type="bibr" rid="R81" style="cursor: pointer; color: rgb(128, 64, 0); font-weight: bold; "><sup>81</sup></xref> Such vasodilation could also enhance sexual function in men by lessening ED. Another investigation showed that men with the lowest vitamin D levels also had 6.13 times the risk of developing hypertension; women with the lowest levels had 2.67 times the risk.<xref ref-type="bibr" rid="R82" style="cursor: pointer; color: rgb(128, 64, 0); font-weight: bold; "><sup>82</sup></xref> Other investigations show a close association between VDD and the likelihood of stroke.<xref ref-type="bibr" rid="R83" style="cursor: pointer; color: rgb(128, 64, 0); font-weight: bold; "><sup>83</sup></xref></p>

<p>We hypothesize that vitamin D optimization through sunlight exposure or vitamin D<sub>3</sub> supplementation would decrease vascular damage caused by hypertension and reduce the risk of ED.</p>

</sec><sec xmlns:oasis="http://docs.oasis-open.org/ns/oasis-exchange/table">

<b>Inflammation in the vascular endothelium</b>

<p>Inflammation is a reaction of damaged tissue that manifests as redness, swelling, pain, tenderness, and heat. It is primarily a protective response against injury. Normal vascular endothelium has anti-inflammatory properties, but endothelial function is impaired in the presence of inflammatory conditions and increased oxidative stress.<xref ref-type="bibr" rid="R17" style="cursor: pointer; color: rgb(128, 64, 0); font-weight: bold; "><sup>17</sup></xref><sup>,</sup><xref ref-type="bibr" rid="R84" style="cursor: pointer; color: rgb(128, 64, 0); font-weight: bold; "><sup>84</sup></xref> When injurious agents persist or healing is disturbed, inflammation, tissue injury, and attempts at repair coexist. This combination of factors can lead to chronic inflammation, harming many body systems, including the vascular system.<xref ref-type="bibr" rid="R85" style="cursor: pointer; color: rgb(128, 64, 0); font-weight: bold; "><sup>85</sup></xref> Inflammation drives the formation, progression, and rupture of atherosclerotic plaques; it is one of the stimuli that cause CAMs to further recruit inflammatory blood monocytes that adhere to the endothelium, and through chemotactic stimulus by inflammatory proteins known as chemokines and inflammatory cytokines, enter between the endothelial cells and invade the intima of the blood vessel. In the intima, they mature into macrophages, which engulf lipids and create foam cells, leading to atherosclerotic lesions.<xref ref-type="bibr" rid="R86" style="cursor: pointer; color: rgb(128, 64, 0); font-weight: bold; "><sup>86</sup></xref><sup>,</sup><xref ref-type="bibr" rid="R87" style="cursor: pointer; color: rgb(128, 64, 0); font-weight: bold; "><sup>87</sup></xref> Macrophages also release growth factors that are destructive to blood vessels.<xref ref-type="bibr" rid="R88" style="cursor: pointer; color: rgb(128, 64, 0); font-weight: bold; "><sup>88</sup></xref><sup>-</sup><xref ref-type="bibr" rid="R91" style="cursor: pointer; color: rgb(128, 64, 0); font-weight: bold; "><sup>91</sup></xref><sup>,</sup> Even subclinical inflammation affects endothelial function and is involved in all stages of atherosclerosis.<xref ref-type="bibr" rid="R17" style="cursor: pointer; color: rgb(128, 64, 0); font-weight: bold; "><sup>17</sup></xref> Thus, the endothelium as well as the entire blood vessel is damaged, and atherosclerosis proceeds.</p>

<p>ED is also closely associated with inflammation. C-reactive protein (CRP), a major marker of inflammation, is significantly higher in patients with ED than in subjects without ED.<xref ref-type="bibr" rid="R92" style="cursor: pointer; color: rgb(128, 64, 0); font-weight: bold; "><sup>92</sup></xref><sup>,</sup><xref ref-type="bibr" rid="R93" style="cursor: pointer; color: rgb(128, 64, 0); font-weight: bold; "><sup>93</sup></xref> Interestingly, CRP itself reduces production of NO, leading to further vascular damage.<xref ref-type="bibr" rid="R94" style="cursor: pointer; color: rgb(128, 64, 0); font-weight: bold; "><sup>94</sup></xref> Also, CAMs are increased in men with ED who have not manifested cardiovascular risk factors or overt vascular damage.<xref ref-type="bibr" rid="R95" style="cursor: pointer; color: rgb(128, 64, 0); font-weight: bold; "><sup>95</sup></xref> Another marker of inflammation is tumor necrosis factor ? (TNF?), an inflammatory cytokine that is markedly elevated in men with ED and is another common link between ED and CVD.<xref ref-type="bibr" rid="R96" style="cursor: pointer; color: rgb(128, 64, 0); font-weight: bold; "><sup>96</sup></xref></p>

<p>Vitamin D may promote vascular health by inhibiting inflammation.<xref ref-type="bibr" rid="R97" style="cursor: pointer; color: rgb(128, 64, 0); font-weight: bold; "><sup>97</sup></xref> Vitamin D supplements and injections may lower CRP levels as much as 40%<xref ref-type="bibr" rid="R98" style="cursor: pointer; color: rgb(128, 64, 0); font-weight: bold; "><sup>98</sup></xref> and improve cytokine profiles; it inhibits the production of proinflammatory cytokines<xref ref-type="bibr" rid="R99" style="cursor: pointer; color: rgb(128, 64, 0); font-weight: bold; "><sup>99</sup></xref><sup>,</sup><xref ref-type="bibr" rid="R100" style="cursor: pointer; color: rgb(128, 64, 0); font-weight: bold; "><sup>100</sup></xref> while stimulating the production of anti-inflammatory cytokines.<xref ref-type="bibr" rid="R100" style="cursor: pointer; color: rgb(128, 64, 0); font-weight: bold; "><sup>100</sup></xref><sup>,</sup><xref ref-type="bibr" rid="R101" style="cursor: pointer; color: rgb(128, 64, 0); font-weight: bold; "><sup>101</sup></xref> One pro-inflammatory cytokine, TNF?, is inversely related to regular exposure to sunlight and artificial sources of UVB among women,<xref ref-type="bibr" rid="R102" style="cursor: pointer; color: rgb(128, 64, 0); font-weight: bold; "><sup>102</sup></xref> and the same is probably true for men. Two CAMs induced by TNF? are also significantly decreased after incubation with activated vitamin D.<xref ref-type="bibr" rid="R103" style="cursor: pointer; color: rgb(128, 64, 0); font-weight: bold; "><sup>103</sup></xref> In addition, Oh and colleagues have shown that in patients with type 2 diabetes, active vitamin D inhibits foam cell formation and suppresses macrophage cholesterol uptake,<xref ref-type="bibr" rid="R104" style="cursor: pointer; color: rgb(128, 64, 0); font-weight: bold; "><sup>104</sup></xref><sup>,</sup><xref ref-type="bibr" rid="R105" style="cursor: pointer; color: rgb(128, 64, 0); font-weight: bold; "><sup>105</sup></xref> inhibiting the inflammatory atherosclerotic process described earlier.</p>

<p>We hypothesize that vitamin D optimization through sunlight exposure or vitamin D<sub>3</sub> supplementation would decrease vascular damage caused by inflammation and reduce the risk of ED. We searched pubmed.gov for evidence contradicting our hypothesis regarding VDD and ED but found none.</p>

</sec><sec xmlns:oasis="http://docs.oasis-open.org/ns/oasis-exchange/table">

<b>Other influences of vitamin D on ED</b>

<sec>

<b>Endothelial-progenitor cells</b>

<p>Endothelial progenitor cells (EPCs) are necessary for maintaining the health of the arterial endothelium. VDD is associated with depletion of EPCs and consequent END in patients with type 2 DM.<xref ref-type="bibr" rid="R106" style="cursor: pointer; color: rgb(128, 64, 0); font-weight: bold; "><sup>106</sup></xref> This research also showed that VDD was associated with reduced vasodilation as measured by brachial artery flow–mediated dilation.</p>

</sec>

<sec>

<b>NO synthases</b>

<p>NO synthases (NOS) are a family of enzymes that catalyze the production of NO from <sc>l</sc>-arginine. Activated vitamin D stimulates the production of substantial quantities of NOS and NO in macrophages produced in response to tuberculosis,<xref ref-type="bibr" rid="R107" style="cursor: pointer; color: rgb(128, 64, 0); font-weight: bold; "><sup>107</sup></xref> in bone,<xref ref-type="bibr" rid="R108" style="cursor: pointer; color: rgb(128, 64, 0); font-weight: bold; "><sup>108</sup></xref> and in endothelial cells,<xref ref-type="bibr" rid="R109" style="cursor: pointer; color: rgb(128, 64, 0); font-weight: bold; "><sup>109</sup></xref> the last being vital to vascular dilation and thereby important to inhibiting ED. This behavior may explain why endothelium-derived, NO-evoked dilation is halved in arteries from vitamin D–deficient male rats.<xref ref-type="bibr" rid="R110" style="cursor: pointer; color: rgb(128, 64, 0); font-weight: bold; "><sup>110</sup></xref></p>

</sec>

<sec>

<b>PAD</b>

<p>PAD is a CVD that is closely associated with the presence of ED. Chua and colleagues have shown that VDD could be an easily correctable independent risk factor for PAD.<xref ref-type="bibr" rid="R111" style="cursor: pointer; color: rgb(128, 64, 0); font-weight: bold; "><sup>111</sup></xref></p>

</sec>

<sec>

<b>Platelet activation</b>

<p>Platelet activation by proinflammatory factors is another aspect of END. In experiments, vitamin D attenuates platelet activation while reducing the expression of two CAMs, VCAM-1 and MT1-MMP.<xref ref-type="bibr" rid="R112" style="cursor: pointer; color: rgb(128, 64, 0); font-weight: bold; "><sup>112</sup></xref> Researchers in Israel also identified 50 patients who had a heart attack or an episode of unstable angina, placing half of them on a regimen of 4,000 IU of vitamin D daily for 5 d. The vitamin D group showed a decrease in VCAM-1 as well as another inflammation marker, interleukin 6. The patients who did not receive vitamin D showed clear increases in both inflammation markers.<xref ref-type="bibr" rid="R113" style="cursor: pointer; color: rgb(128, 64, 0); font-weight: bold; "><sup>113</sup></xref> The researchers stated, “VCAM-1 is central to atherosclerotic plaque formation and [interleukin 6] is broadly associated with coronary risk.” Both studies indicate that vitamin D has actions that reduce END and thereby have a positive influence on ED.</p>

</sec>

<sec>

<b>Vascular smooth-muscle cell proliferation</b>

<p>Vascular smooth-muscle cell (VSMC) proliferation is part of the process of atherosclerosis. Vitamin D has an antiproliferative influence on VSMC,<xref ref-type="bibr" rid="R114" style="cursor: pointer; color: rgb(128, 64, 0); font-weight: bold; "><sup>114</sup></xref><sup>,</sup><xref ref-type="bibr" rid="R115" style="cursor: pointer; color: rgb(128, 64, 0); font-weight: bold; "><sup>115</sup></xref> which indicates antiatherosclerotic properties that may positively influence ED.</p>

</sec>

<sec>

<b>Vasodilation</b>

<p>Vasodilation is vital to achieving erection. VDD is inversely associated with flow-mediated vasodilation, END, and arterial stiffness irrespective of the traditional risk factors for CVD and ED<xref ref-type="bibr" rid="R33" style="cursor: pointer; color: rgb(128, 64, 0); font-weight: bold; "><sup>33</sup></xref> discussed here. Therefore, VDD—in addition to exacerbating the classical risk factors for CVD—may directly lead to ED.</p>

</sec>

</sec><sec xmlns:oasis="http://docs.oasis-open.org/ns/oasis-exchange/table">

<b>Nonvascular conditions comorbid with ED and influenced by vitamin D</b>

<p>We have thus far discussed the relationship of ED to CVD and considered the influence of vitamin D levels or treatment on both disorders. Evidence in addition to that presented in this review in support of the hypothesis that VDD contributes to ED risk was sought by searching pubmed.gov for papers linking ED to sun exposure, race, and disorders linked to VDD, and whether animal models regarding vitamin D and ED had been conducted. No evidence linking ED to sun exposure was found. No animal model studies of ED and vitamin D were found. In a cross-sectional study in the United States in 2000 and 2001, the estimated prevalence of ED was “21.9% (95% CI, 18.8-24.9) in whites, 24.4% (95% CI, 18.4-30.5) in blacks, and 19.9% (95% CI, 13.9-25.9) in Hispanics.”<xref ref-type="bibr" rid="R116" style="cursor: pointer; color: rgb(128, 64, 0); font-weight: bold; "><sup>116</sup></xref> Another paper reported that Black and Hispanic men in the Boston area had 25% higher rate of ED, but attributed the finding to socioeconomic status rather than race<xref ref-type="bibr" rid="R117" style="cursor: pointer; color: rgb(128, 64, 0); font-weight: bold; "><sup>117</sup></xref></p>

<p>Several other nonvascular diseases and conditions are closely associated with both ED and VDD, strengthening the hypothesis that VDD contributes to ED and offering another avenue whereby vitamin D optimization might mitigate or reverse it. Those diseases and conditions include Alzheimer,<xref ref-type="bibr" rid="R118" style="cursor: pointer; color: rgb(128, 64, 0); font-weight: bold; "><sup>118</sup></xref><sup>,</sup><xref ref-type="bibr" rid="R119" style="cursor: pointer; color: rgb(128, 64, 0); font-weight: bold; "><sup>119</sup></xref> asthma,<xref ref-type="bibr" rid="R120" style="cursor: pointer; color: rgb(128, 64, 0); font-weight: bold; "><sup>120</sup></xref><sup>,</sup><xref ref-type="bibr" rid="R121" style="cursor: pointer; color: rgb(128, 64, 0); font-weight: bold; "><sup>121</sup></xref> chronic kidney disease,<xref ref-type="bibr" rid="R122" style="cursor: pointer; color: rgb(128, 64, 0); font-weight: bold; "><sup>122</sup></xref><sup>-</sup><xref ref-type="bibr" rid="R124" style="cursor: pointer; color: rgb(128, 64, 0); font-weight: bold; "><sup>124</sup></xref> depression,<xref ref-type="bibr" rid="R125" style="cursor: pointer; color: rgb(128, 64, 0); font-weight: bold; "><sup>125</sup></xref><sup>,</sup><xref ref-type="bibr" rid="R126" style="cursor: pointer; color: rgb(128, 64, 0); font-weight: bold; "><sup>126</sup></xref> falls and fractures,<xref ref-type="bibr" rid="R127" style="cursor: pointer; color: rgb(128, 64, 0); font-weight: bold; "><sup>127</sup></xref><sup>,</sup><xref ref-type="bibr" rid="R128" style="cursor: pointer; color: rgb(128, 64, 0); font-weight: bold; "><sup>128</sup></xref> metabolic syndrome,<xref ref-type="bibr" rid="R129" style="cursor: pointer; color: rgb(128, 64, 0); font-weight: bold; "><sup>129</sup></xref><sup>,</sup><xref ref-type="bibr" rid="R130" style="cursor: pointer; color: rgb(128, 64, 0); font-weight: bold; "><sup>130</sup></xref> MS,<xref ref-type="bibr" rid="R131" style="cursor: pointer; color: rgb(128, 64, 0); font-weight: bold; "><sup>131</sup></xref><sup>-</sup><xref ref-type="bibr" rid="R134" style="cursor: pointer; color: rgb(128, 64, 0); font-weight: bold; "><sup>134</sup></xref> obesity,<xref ref-type="bibr" rid="R135" style="cursor: pointer; color: rgb(128, 64, 0); font-weight: bold; "><sup>135</sup></xref><sup>,</sup><xref ref-type="bibr" rid="R136" style="cursor: pointer; color: rgb(128, 64, 0); font-weight: bold; "><sup>136</sup></xref> Parkinson,<xref ref-type="bibr" rid="R137" style="cursor: pointer; color: rgb(128, 64, 0); font-weight: bold; "><sup>137</sup></xref><sup>,</sup><xref ref-type="bibr" rid="R138" style="cursor: pointer; color: rgb(128, 64, 0); font-weight: bold; "><sup>138</sup></xref> periodontal disease,<xref ref-type="bibr" rid="R139" style="cursor: pointer; color: rgb(128, 64, 0); font-weight: bold; "><sup>139</sup></xref><sup>,</sup><xref ref-type="bibr" rid="R140" style="cursor: pointer; color: rgb(128, 64, 0); font-weight: bold; "><sup>140</sup></xref> psoriasis,<xref ref-type="bibr" rid="R141" style="cursor: pointer; color: rgb(128, 64, 0); font-weight: bold; "><sup>141</sup></xref><sup>,</sup><xref ref-type="bibr" rid="R142" style="cursor: pointer; color: rgb(128, 64, 0); font-weight: bold; "><sup>142</sup></xref> and smoking.<xref ref-type="bibr" rid="R143" style="cursor: pointer; color: rgb(128, 64, 0); font-weight: bold; "><sup>143</sup></xref><sup>,</sup><xref ref-type="bibr" rid="R144" style="cursor: pointer; color: rgb(128, 64, 0); font-weight: bold; "><sup>144</sup></xref><xref ref-type="table" rid="T1" style="cursor: pointer; color: rgb(128, 64, 0); font-weight: bold; ">Table 1</xref> summarizes research regarding those diseases and conditions. For all of these diseases, VDD appears to be an important risk factor. Thus, avoiding VDD earlier in life may reduce the risk of ED. In addition, for some of the diseases such as atopic dermatitis<xref ref-type="bibr" rid="R145" style="cursor: pointer; color: rgb(128, 64, 0); font-weight: bold; "><sup>145</sup></xref><sup>,</sup><xref ref-type="bibr" rid="R146" style="cursor: pointer; color: rgb(128, 64, 0); font-weight: bold; "><sup>146</sup></xref> and multiple sclerosis, increasing vitamin D intake or production can reduce the symptoms and may also reduce the risk of ED.</p>

<fieldset><table-wrap id="T1" position="float">

<b><b>Table&nbsp;1.</b> Evidence for influences of vitamin D on nonvascular diseases and conditions associated with ED</b>

<table>

<colgroup span="4">

<col colnum="1" colname="col1" colwidth="15.63%">

<col colnum="2" colname="col2" colwidth="56.42%">

<col colnum="3" colname="col3" colwidth="12.36%">

<col colnum="4" colname="col4" colwidth="15.59%">

</colgroup><thead>

<tr>

<td valign="top" align="center" style="border-top-width: 0px; border-top-style: none; border-top-color: rgb(34, 34, 34); border-bottom-width: 0px; border-bottom-style: none; border-bottom-color: rgb(34, 34, 34); ">Disease or condition</td>

<td valign="top" align="center" style="border-top-width: 0px; border-top-style: none; border-top-color: rgb(34, 34, 34); border-bottom-width: 0px; border-bottom-style: none; border-bottom-color: rgb(34, 34, 34); ">Finding<break>(some measure of correlation)</break></td>

<td valign="top" align="center" style="border-top-width: 0px; border-top-style: none; border-top-color: rgb(34, 34, 34); border-bottom-width: 0px; border-bottom-style: none; border-bottom-color: rgb(34, 34, 34); ">Reference</td>

<td valign="top" align="center" style="border-top-width: 0px; border-top-style: none; border-top-color: rgb(34, 34, 34); border-bottom-width: 0px; border-bottom-style: none; border-bottom-color: rgb(34, 34, 34); ">Evidence for vitamin D<break>deficiency</break></td>

</tr>

</thead>

<tbody>

<tr>

<td valign="top" align="center" style="border-bottom-width: 0px; border-bottom-style: none; border-bottom-color: rgb(34, 34, 34); ">Alzheimer disease</td>

<td valign="top" align="center" style="border-bottom-width: 0px; border-bottom-style: none; border-bottom-color: rgb(34, 34, 34); ">Loss of erection was reported in 53% of 55 male Alzheimer disease patients with a mean age of 70.25 y. Loss of erection is not related to degree of cognitive impairment, age, or depression.</td>

<td valign="top" align="center" style="border-bottom-width: 0px; border-bottom-style: none; border-bottom-color: rgb(34, 34, 34); ">

<xref ref-type="bibr" rid="R118" style="cursor: pointer; color: rgb(128, 64, 0); font-weight: bold; ">118</xref>

</td>

<td valign="top" align="center" style="border-bottom-width: 0px; border-bottom-style: none; border-bottom-color: rgb(34, 34, 34); ">

<xref ref-type="bibr" rid="R119" style="cursor: pointer; color: rgb(128, 64, 0); font-weight: bold; ">119</xref>

</td>

</tr>

<tr>

<td valign="top" align="center" style="border-bottom-width: 0px; border-bottom-style: none; border-bottom-color: rgb(34, 34, 34); ">Asthma</td>

<td valign="top" align="center" style="border-bottom-width: 0px; border-bottom-style: none; border-bottom-color: rgb(34, 34, 34); ">Subjects with asthma experienced a 1.9-fold (95% confidence interval [CI], 1.3–2.9; p = 0.002) increase in incident ED.</td>

<td valign="top" align="center" style="border-bottom-width: 0px; border-bottom-style: none; border-bottom-color: rgb(34, 34, 34); ">

<xref ref-type="bibr" rid="R120" style="cursor: pointer; color: rgb(128, 64, 0); font-weight: bold; ">120</xref>

</td>

<td valign="top" align="center" style="border-bottom-width: 0px; border-bottom-style: none; border-bottom-color: rgb(34, 34, 34); ">

<xref ref-type="bibr" rid="R121" style="cursor: pointer; color: rgb(128, 64, 0); font-weight: bold; ">121</xref>

</td>

</tr>

<tr>

<td valign="top" align="center" style="border-bottom-width: 0px; border-bottom-style: none; border-bottom-color: rgb(34, 34, 34); ">Chronic kidney disease</td>

<td valign="top" align="center" style="border-bottom-width: 0px; border-bottom-style: none; border-bottom-color: rgb(34, 34, 34); ">Prevalence of ED of various degrees was 87.7% among 73 patients with chronic kidney disease in Iran.</td>

<td valign="top" align="center" style="border-bottom-width: 0px; border-bottom-style: none; border-bottom-color: rgb(34, 34, 34); ">

<xref ref-type="bibr" rid="R122" style="cursor: pointer; color: rgb(128, 64, 0); font-weight: bold; ">122</xref>

</td>

<td valign="top" align="center" style="border-bottom-width: 0px; border-bottom-style: none; border-bottom-color: rgb(34, 34, 34); "><xref ref-type="bibr" rid="R123" style="cursor: pointer; color: rgb(128, 64, 0); font-weight: bold; ">123</xref>,<xref ref-type="bibr" rid="R124" style="cursor: pointer; color: rgb(128, 64, 0); font-weight: bold; ">124</xref></td>

</tr>

<tr>

<td valign="top" align="center" style="border-bottom-width: 0px; border-bottom-style: none; border-bottom-color: rgb(34, 34, 34); ">Depression</td>

<td valign="top" align="center" style="border-bottom-width: 0px; border-bottom-style: none; border-bottom-color: rgb(34, 34, 34); ">Comorbid conditions ED and depression are highly prevalent in men, and men with high depression scores are nearly twice as likely to report ED than nondepressed men.</td>

<td valign="top" align="center" style="border-bottom-width: 0px; border-bottom-style: none; border-bottom-color: rgb(34, 34, 34); ">

<xref ref-type="bibr" rid="R125" style="cursor: pointer; color: rgb(128, 64, 0); font-weight: bold; ">125</xref>

</td>

<td valign="top" align="center" style="border-bottom-width: 0px; border-bottom-style: none; border-bottom-color: rgb(34, 34, 34); ">

<xref ref-type="bibr" rid="R126" style="cursor: pointer; color: rgb(128, 64, 0); font-weight: bold; ">126</xref>

</td>

</tr>

<tr>

<td valign="top" align="center" style="border-bottom-width: 0px; border-bottom-style: none; border-bottom-color: rgb(34, 34, 34); ">Falls, fractures</td>

<td valign="top" align="center" style="border-bottom-width: 0px; border-bottom-style: none; border-bottom-color: rgb(34, 34, 34); ">ED (2.01; 95% CI, 1.30–3.09) was associated with increased risk of osteoporotic fractures in adjusted models.</td>

<td valign="top" align="center" style="border-bottom-width: 0px; border-bottom-style: none; border-bottom-color: rgb(34, 34, 34); ">

<xref ref-type="bibr" rid="R127" style="cursor: pointer; color: rgb(128, 64, 0); font-weight: bold; ">127</xref>

</td>

<td valign="top" align="center" style="border-bottom-width: 0px; border-bottom-style: none; border-bottom-color: rgb(34, 34, 34); ">

<xref ref-type="bibr" rid="R128" style="cursor: pointer; color: rgb(128, 64, 0); font-weight: bold; ">128</xref>

</td>

</tr>

<tr>

<td valign="top" align="center" style="border-bottom-width: 0px; border-bottom-style: none; border-bottom-color: rgb(34, 34, 34); ">Metabolic syndrome</td>

<td valign="top" align="center" style="border-bottom-width: 0px; border-bottom-style: none; border-bottom-color: rgb(34, 34, 34); ">Metabolic syndrome appears to be strongly related to ED.</td>

<td valign="top" align="center" style="border-bottom-width: 0px; border-bottom-style: none; border-bottom-color: rgb(34, 34, 34); ">

<xref ref-type="bibr" rid="R129" style="cursor: pointer; color: rgb(128, 64, 0); font-weight: bold; ">129</xref>

</td>

<td valign="top" align="center" style="border-bottom-width: 0px; border-bottom-style: none; border-bottom-color: rgb(34, 34, 34); ">

<xref ref-type="bibr" rid="R130" style="cursor: pointer; color: rgb(128, 64, 0); font-weight: bold; ">130</xref>

</td>

</tr>

<tr>

<td valign="top" align="center" style="border-bottom-width: 0px; border-bottom-style: none; border-bottom-color: rgb(34, 34, 34); ">Multiple sclerosis</td>

<td valign="top" align="center" style="border-bottom-width: 0px; border-bottom-style: none; border-bottom-color: rgb(34, 34, 34); ">91% of men with multiple sclerosis report having symptoms of either ED or impotence.</td>

<td valign="top" align="center" style="border-bottom-width: 0px; border-bottom-style: none; border-bottom-color: rgb(34, 34, 34); "><xref ref-type="bibr" rid="R131" style="cursor: pointer; color: rgb(128, 64, 0); font-weight: bold; ">131</xref>,<xref ref-type="bibr" rid="R132" style="cursor: pointer; color: rgb(128, 64, 0); font-weight: bold; ">132</xref></td>

<td valign="top" align="center" style="border-bottom-width: 0px; border-bottom-style: none; border-bottom-color: rgb(34, 34, 34); "><xref ref-type="bibr" rid="R133" style="cursor: pointer; color: rgb(128, 64, 0); font-weight: bold; ">133</xref>,<xref ref-type="bibr" rid="R134" style="cursor: pointer; color: rgb(128, 64, 0); font-weight: bold; ">134</xref></td>

</tr>

<tr>

<td valign="top" align="center" style="border-bottom-width: 0px; border-bottom-style: none; border-bottom-color: rgb(34, 34, 34); ">Obesity</td>

<td valign="top" align="center" style="border-bottom-width: 0px; border-bottom-style: none; border-bottom-color: rgb(34, 34, 34); ">Obesity in Taiwanese military conscripts predicted more than an 83-times-increased risk of ED.</td>

<td valign="top" align="center" style="border-bottom-width: 0px; border-bottom-style: none; border-bottom-color: rgb(34, 34, 34); ">

<xref ref-type="bibr" rid="R135" style="cursor: pointer; color: rgb(128, 64, 0); font-weight: bold; ">135</xref>

</td>

<td valign="top" align="center" style="border-bottom-width: 0px; border-bottom-style: none; border-bottom-color: rgb(34, 34, 34); ">

<xref ref-type="bibr" rid="R136" style="cursor: pointer; color: rgb(128, 64, 0); font-weight: bold; ">136</xref>

</td>

</tr>

<tr>

<td valign="top" align="center" style="border-bottom-width: 0px; border-bottom-style: none; border-bottom-color: rgb(34, 34, 34); ">Parkinson disease</td>

<td valign="top" align="center" style="border-bottom-width: 0px; border-bottom-style: none; border-bottom-color: rgb(34, 34, 34); ">ED was severe in 54% of Parkinson cases and moderate in 26.6%.</td>

<td valign="top" align="center" style="border-bottom-width: 0px; border-bottom-style: none; border-bottom-color: rgb(34, 34, 34); ">

<xref ref-type="bibr" rid="R137" style="cursor: pointer; color: rgb(128, 64, 0); font-weight: bold; ">137</xref>

</td>

<td valign="top" align="center" style="border-bottom-width: 0px; border-bottom-style: none; border-bottom-color: rgb(34, 34, 34); ">

<xref ref-type="bibr" rid="R138" style="cursor: pointer; color: rgb(128, 64, 0); font-weight: bold; ">138</xref>

</td>

</tr>

<tr>

<td valign="top" align="center" style="border-bottom-width: 0px; border-bottom-style: none; border-bottom-color: rgb(34, 34, 34); ">Periodontal disease</td>

<td valign="top" align="center" style="border-bottom-width: 0px; border-bottom-style: none; border-bottom-color: rgb(34, 34, 34); ">Chronic periodontal disease was significantly more prevalent among men with mild ED (p = 0.004) and moderate to severe ED (p = 0.007) than in men without ED.</td>

<td valign="top" align="center" style="border-bottom-width: 0px; border-bottom-style: none; border-bottom-color: rgb(34, 34, 34); ">

<xref ref-type="bibr" rid="R139" style="cursor: pointer; color: rgb(128, 64, 0); font-weight: bold; ">139</xref>

</td>

<td valign="top" align="center" style="border-bottom-width: 0px; border-bottom-style: none; border-bottom-color: rgb(34, 34, 34); ">

<xref ref-type="bibr" rid="R140" style="cursor: pointer; color: rgb(128, 64, 0); font-weight: bold; ">140</xref>

</td>

</tr>

<tr>

<td valign="top" align="center" style="border-bottom-width: 0px; border-bottom-style: none; border-bottom-color: rgb(34, 34, 34); ">Psoriasis</td>

<td valign="top" align="center" style="border-bottom-width: 0px; border-bottom-style: none; border-bottom-color: rgb(34, 34, 34); ">Patients with ED were more likely to have been diagnosed with psoriasis before the index date than controls (odds ratio = 3.85; 95% confidence interval l = 2.72–5.44)</td>

<td valign="top" align="center" style="border-bottom-width: 0px; border-bottom-style: none; border-bottom-color: rgb(34, 34, 34); ">

<xref ref-type="bibr" rid="R141" style="cursor: pointer; color: rgb(128, 64, 0); font-weight: bold; ">141</xref>

</td>

<td valign="top" align="center" style="border-bottom-width: 0px; border-bottom-style: none; border-bottom-color: rgb(34, 34, 34); ">

<xref ref-type="bibr" rid="R142" style="cursor: pointer; color: rgb(128, 64, 0); font-weight: bold; ">142</xref>

</td>

</tr>

<tr>

<td valign="top" align="center" style="border-bottom-width: 0px; border-bottom-style: none; border-bottom-color: rgb(34, 34, 34); ">Smoking</td>

<td valign="top" align="center" style="border-bottom-width: 0px; border-bottom-style: none; border-bottom-color: rgb(34, 34, 34); ">In comparison with never smokers, the OR of ED was 2.41 for current smokers and 2.15 for ex-smokers and increased with duration of the habit.</td>

<td valign="top" align="center" style="border-bottom-width: 0px; border-bottom-style: none; border-bottom-color: rgb(34, 34, 34); ">

<xref ref-type="bibr" rid="R143" style="cursor: pointer; color: rgb(128, 64, 0); font-weight: bold; ">143</xref>

</td>

<td valign="top" align="center" style="border-bottom-width: 0px; border-bottom-style: none; border-bottom-color: rgb(34, 34, 34); ">

<xref ref-type="bibr" rid="R144" style="cursor: pointer; color: rgb(128, 64, 0); font-weight: bold; ">144</xref>

</td>

</tr>

<tr>

<td valign="top" align="center" style="border-bottom-width: 0px; border-bottom-style: none; border-bottom-color: rgb(34, 34, 34); ">Atopic dermatitis</td>

<td valign="top" align="center" style="border-bottom-width: 0px; border-bottom-style: none; border-bottom-color: rgb(34, 34, 34); ">cases were more likely to have prior AD than controls (OR = 1.60; 95% CI = 1.42–1.80, p &lt; 0.001) after multifactorial adjustment</td>

<td valign="top" align="center" style="border-bottom-width: 0px; border-bottom-style: none; border-bottom-color: rgb(34, 34, 34); ">

<xref ref-type="bibr" rid="R145" style="cursor: pointer; color: rgb(128, 64, 0); font-weight: bold; ">145</xref>

</td>

<td valign="top" align="center" style="border-bottom-width: 0px; border-bottom-style: none; border-bottom-color: rgb(34, 34, 34); ">

<xref ref-type="bibr" rid="R146" style="cursor: pointer; color: rgb(128, 64, 0); font-weight: bold; ">146</xref>

</td>

</tr>

</tbody>

</table>

</table-wrap></fieldset>

</sec></div><img src="./dertmato 7_files/delete.png" style="display:inline;" role=".section_5"><h4 class="section_title" style="color: rgb(101, 77, 62); "><b>Conclusion</b></h4><br><br><div class="section_5">

<p xmlns:oasis="http://docs.oasis-open.org/ns/oasis-exchange/table">The research presented suggests that many common mechanisms underlie both CVD and ED, and that VDD is closely associated with both disorders. We hypothesize that optimizing serum vitamin D levels through sunlight exposure or vitamin D supplementation helps delay the onset of ED. Coupled with positive changes in lifestyle, such optimization may restore normal sexual function to some men. This hypothesis should be tested through observational and intervention studies. If proven by further research, such therapy would offer an alternative or complement to phosphodiesterase-5 inhibitors, which, though exceptionally effective and a first choice for treatment, have been associated with many negative side effects,<xref ref-type="bibr" rid="R147" style="cursor: pointer; color: rgb(128, 64, 0); font-weight: bold; "><sup>147</sup></xref> and which, because of their efficacy in producing erections, may cause men with ED to ignore the possibility they might have occult underlying CVD.</p>

</div><img src="./dertmato 7_files/delete.png" style="display:inline;" role=".references"><h4 class="section_title" style="color: rgb(101, 77, 62); "><b>References</b></h4><br><br><div class="references"><div id="R1">1.

Pilz&nbsp;S, Tomaschitz&nbsp;A, März&nbsp;W, Drechsler&nbsp;C, Ritz&nbsp;E, Zittermann&nbsp;A, et al.

<article-title xmlns:oasis="http://docs.oasis-open.org/ns/oasis-exchange/table">Vitamin D, cardiovascular disease and mortality</article-title>.

Clin Endocrinol (Oxf)&nbsp;2011;

75:575-84; PMID:&nbsp;<a href="http://www.ncbi.nlm.nih.gov/pubmed/21682758" target="_blank">21682758</a>; DOI:&nbsp;<a href="http://dx.doi.org/10.1111/j.1365-2265.2011.04147.x" target="_blank">10.1111/j.1365-2265.2011.04147.x</a>.

</div><br><div id="R2">2.

Souberbielle&nbsp;JC, Body&nbsp;JJ, Lappe&nbsp;JM, Plebani&nbsp;M, Shoenfeld&nbsp;Y, Wang&nbsp;TJ, et al.

<article-title xmlns:oasis="http://docs.oasis-open.org/ns/oasis-exchange/table">Vitamin D and musculoskeletal health, cardiovascular disease, autoimmunity and cancer: Recommendations for clinical practice</article-title>.

Autoimmun Rev&nbsp;2010;

9:709-15; PMID:&nbsp;<a href="http://www.ncbi.nlm.nih.gov/pubmed/20601202" target="_blank">20601202</a>; DOI:&nbsp;<a href="http://dx.doi.org/10.1016/j.autrev.2010.06.009" target="_blank">10.1016/j.autrev.2010.06.009</a>.

</div><br><div id="R3">3.

Ginde&nbsp;AA, Liu&nbsp;MC, Camargo&nbsp;CA.

<article-title xmlns:oasis="http://docs.oasis-open.org/ns/oasis-exchange/table">Demographic differences and trends of vitamin D insufficiency in the US population, 1988-2004</article-title>.

Arch Intern Med&nbsp;2009;

169:626-32; PMID:&nbsp;<a href="http://www.ncbi.nlm.nih.gov/pubmed/19307527" target="_blank">19307527</a>; DOI:&nbsp;<a href="http://dx.doi.org/10.1001/archinternmed.2008.604" target="_blank">10.1001/archinternmed.2008.604</a>.

</div><br><div id="R4">4.

Ayta&nbsp;IA, McKinlay&nbsp;JB, Krane&nbsp;RJ.

<article-title xmlns:oasis="http://docs.oasis-open.org/ns/oasis-exchange/table">The likely worldwide increase in erectile dysfunction between 1995 and 2025 and some possible policy consequences</article-title>.

BJU Int&nbsp;1999;

84:50-6; PMID:&nbsp;<a href="http://www.ncbi.nlm.nih.gov/pubmed/10444124" target="_blank">10444124</a>; DOI:&nbsp;<a href="http://dx.doi.org/10.1046/j.1464-410x.1999.00142.x" target="_blank">10.1046/j.1464-410x.1999.00142.x</a>.

</div><br><div id="R5">5.

Araujo&nbsp;AB, Hall&nbsp;SA, Ganz&nbsp;P, Chiu&nbsp;GR, Rosen&nbsp;RC, Kupelian&nbsp;V, et al.

<article-title xmlns:oasis="http://docs.oasis-open.org/ns/oasis-exchange/table">Does erectile dysfunction contribute to cardiovascular disease risk prediction beyond the Framingham risk score?</article-title>.

J Am Coll Cardiol&nbsp;2010;

55:350-6; PMID:&nbsp;<a href="http://www.ncbi.nlm.nih.gov/pubmed/20117441" target="_blank">20117441</a>; DOI:&nbsp;<a href="http://dx.doi.org/10.1016/j.jacc.2009.08.058" target="_blank">10.1016/j.jacc.2009.08.058</a>.

</div><br><div id="R6">6.

McKinlay&nbsp;JB.

<article-title xmlns:oasis="http://docs.oasis-open.org/ns/oasis-exchange/table">The worldwide prevalence and epidemiology of erectile dysfunction</article-title>.

Int J Impot Res&nbsp;2000;

12:S6-11; PMID:&nbsp;<a href="http://www.ncbi.nlm.nih.gov/pubmed/11035380" target="_blank">11035380</a>; DOI:&nbsp;<a href="http://dx.doi.org/10.1038/sj.ijir.3900567" target="_blank">10.1038/sj.ijir.3900567</a>.

</div><br><div id="R7">7.

Schouten&nbsp;BW, Bohnen&nbsp;AM, Dohle&nbsp;GR, Groeneveld&nbsp;FP, Willemsen&nbsp;S, Thomas&nbsp;S, et al.

<article-title xmlns:oasis="http://docs.oasis-open.org/ns/oasis-exchange/table">Risk factors for deterioration of erectile function: the Krimpen study</article-title>.

Int J Androl&nbsp;2009;

32:166-75; PMID:&nbsp;<a href="http://www.ncbi.nlm.nih.gov/pubmed/18067566" target="_blank">18067566</a>; DOI:&nbsp;<a href="http://dx.doi.org/10.1111/j.1365-2605.2007.00830.x" target="_blank">10.1111/j.1365-2605.2007.00830.x</a>.

</div><br><div id="R8">8.

Valles Antuña&nbsp;C, Fernández Gómez&nbsp;JM, Escaf&nbsp;S, Fernández-González&nbsp;F.

<article-title xmlns:oasis="http://docs.oasis-open.org/ns/oasis-exchange/table">Neurogenic etiology in patients with erectile dysfunction</article-title>.

Arch Esp Urol&nbsp;2008;

61:403-11; PMID:&nbsp;<a href="http://www.ncbi.nlm.nih.gov/pubmed/18581678" target="_blank">18581678</a>.

</div><br><div id="R9">9.

Kloner&nbsp;RA.

<article-title xmlns:oasis="http://docs.oasis-open.org/ns/oasis-exchange/table">Erectile dysfunction and cardiovascular risk factors</article-title>.

Urol Clin North Am&nbsp;2005;

32:397-402, v; PMID:&nbsp;<a href="http://www.ncbi.nlm.nih.gov/pubmed/16291032" target="_blank">16291032</a>; DOI:&nbsp;<a href="http://dx.doi.org/10.1016/j.ucl.2005.08.005" target="_blank">10.1016/j.ucl.2005.08.005</a>.

</div><br><div id="R10">10.

Saigal&nbsp;CS, Wessells&nbsp;H, Pace&nbsp;J, Schonlau&nbsp;M, Wilt&nbsp;TJ.

<article-title xmlns:oasis="http://docs.oasis-open.org/ns/oasis-exchange/table">Predictors and prevalence of erectile dysfunction in a racially diverse population</article-title>.

Arch Intern Med&nbsp;2006;

166:207-12; PMID:&nbsp;<a href="http://www.ncbi.nlm.nih.gov/pubmed/16432090" target="_blank">16432090</a>; DOI:&nbsp;<a href="http://dx.doi.org/10.1001/archinte.166.2.207" target="_blank">10.1001/archinte.166.2.207</a>.

</div><br><div id="R11">11.

Billups&nbsp;KL, Bank&nbsp;AJ, Padma-Nathan&nbsp;H, Katz&nbsp;SD, Williams&nbsp;RA.

<article-title xmlns:oasis="http://docs.oasis-open.org/ns/oasis-exchange/table">Erectile dysfunction as a harbinger for increased cardiometabolic risk</article-title>.

Int J Impot Res&nbsp;2008;

20:236-42; PMID:&nbsp;<a href="http://www.ncbi.nlm.nih.gov/pubmed/18200018" target="_blank">18200018</a>; DOI:&nbsp;<a href="http://dx.doi.org/10.1038/sj.ijir.3901634" target="_blank">10.1038/sj.ijir.3901634</a>.

</div><br><div id="R12">12.

Solomon&nbsp;H, Man&nbsp;JW, Jackson&nbsp;G.

<article-title xmlns:oasis="http://docs.oasis-open.org/ns/oasis-exchange/table">Erectile dysfunction and the cardiovascular patient: endothelial dysfunction is the common denominator</article-title>.

Heart&nbsp;2003;

89:251-3; PMID:&nbsp;<a href="http://www.ncbi.nlm.nih.gov/pubmed/12591819" target="_blank">12591819</a>; DOI:&nbsp;<a href="http://dx.doi.org/10.1136/heart.89.3.251" target="_blank">10.1136/heart.89.3.251</a>.

</div><br><div id="R13">13.

Meldrum&nbsp;DR, Gambone&nbsp;JC, Morris&nbsp;MA, Meldrum&nbsp;DA, Esposito&nbsp;K, Ignarro&nbsp;LJ.

<article-title xmlns:oasis="http://docs.oasis-open.org/ns/oasis-exchange/table">The link between erectile and cardiovascular health: the canary in the coal mine</article-title>.

Am J Cardiol&nbsp;2011;

108:599-606; PMID:&nbsp;<a href="http://www.ncbi.nlm.nih.gov/pubmed/21624550" target="_blank">21624550</a>; DOI:&nbsp;<a href="http://dx.doi.org/10.1016/j.amjcard.2011.03.093" target="_blank">10.1016/j.amjcard.2011.03.093</a>.

</div><br><div id="R14">14.

Bird&nbsp;IM.

<article-title xmlns:oasis="http://docs.oasis-open.org/ns/oasis-exchange/table">Endothelial nitric oxide synthase activation and nitric oxide function: new light through old windows</article-title>.

J Endocrinol&nbsp;2011;

210:239-41; PMID:&nbsp;<a href="http://www.ncbi.nlm.nih.gov/pubmed/21824899" target="_blank">21824899</a>; DOI:&nbsp;<a href="http://dx.doi.org/10.1530/JOE-11-0216" target="_blank">10.1530/JOE-11-0216</a>.

</div><br><div id="R15">15.

Web MD Erectile Dysfunction Health Center. Erectile dysfunction: how an erection occurs. http://www.webmd.com/erectile-dysfunction/guide/how-an-erection-occurs. Accessed October 29, 2011.</div><br><div id="R16">16.

Ghiadoni&nbsp;L, Taddei&nbsp;S, Virdis&nbsp;A.

<article-title xmlns:oasis="http://docs.oasis-open.org/ns/oasis-exchange/table">Hypertension and endothelial dysfunction: therapeutic approach</article-title>.

Curr Vasc Pharmacol&nbsp;2012;

10:42-60; PMID:&nbsp;<a href="http://www.ncbi.nlm.nih.gov/pubmed/22112351" target="_blank">22112351</a>; DOI:&nbsp;<a href="http://dx.doi.org/10.2174/157016112798829823" target="_blank">10.2174/157016112798829823</a>.

</div><br><div id="R17">17.

Vlachopoulos&nbsp;C, Rokkas&nbsp;K, Ioakeimidis&nbsp;N, Stefanadis&nbsp;C.

<article-title xmlns:oasis="http://docs.oasis-open.org/ns/oasis-exchange/table">Inflammation, metabolic syndrome, erectile dysfunction, and coronary artery disease: common links</article-title>.

Eur Urol&nbsp;2007;

52:1590-600; PMID:&nbsp;<a href="http://www.ncbi.nlm.nih.gov/pubmed/17707576" target="_blank">17707576</a>; DOI:&nbsp;<a href="http://dx.doi.org/10.1016/j.eururo.2007.08.004" target="_blank">10.1016/j.eururo.2007.08.004</a>.

</div><br><div id="R18">18.

Nehra&nbsp;A.

<article-title xmlns:oasis="http://docs.oasis-open.org/ns/oasis-exchange/table">Erectile dysfunction and cardiovascular disease: efficacy and safety of phosphodiesterase type 5 inhibitors in men with both conditions</article-title>.

Mayo Clin Proc&nbsp;2009;

84:139-48; PMID:&nbsp;<a href="http://www.ncbi.nlm.nih.gov/pubmed/19181648" target="_blank">19181648</a>; DOI:&nbsp;<a href="http://dx.doi.org/10.4065/84.2.139" target="_blank">10.4065/84.2.139</a>.

</div><br><div id="R19">19.

Menezes&nbsp;A, Artham&nbsp;S, Lavie&nbsp;CJ, Milani&nbsp;RV, O’Keefe&nbsp;J.

<article-title xmlns:oasis="http://docs.oasis-open.org/ns/oasis-exchange/table">Erectile dysfunction and cardiovascular disease</article-title>.

Postgrad Med&nbsp;2011;

123:7-16; PMID:&nbsp;<a href="http://www.ncbi.nlm.nih.gov/pubmed/21566411" target="_blank">21566411</a>.

</div><br><div id="R20">20.

Kronzon&nbsp;I, Tunick&nbsp;PA.

<article-title xmlns:oasis="http://docs.oasis-open.org/ns/oasis-exchange/table">Aortic atherosclerotic disease and stroke</article-title>.

Circulation&nbsp;2006;

114:63-75; PMID:&nbsp;<a href="http://www.ncbi.nlm.nih.gov/pubmed/16818829" target="_blank">16818829</a>; DOI:&nbsp;<a href="http://dx.doi.org/10.1161/CIRCULATIONAHA.105.593418" target="_blank">10.1161/CIRCULATIONAHA.105.593418</a>.

</div><br><div id="R21">21.

Stöppler MC, Lee D, Kulic D, Peripheral MD. Vascular Disease. Medicine Net.com. http://www.medicinenet.com/peripheral_vascular_disease/article.htm. Accessed January 5, 2012.</div><br><div id="R22">22.

Erectile dysfunction. Mayo Clinic Online. http://www.mayoclinic.com/health/erectile-dysfunction/HB00074 Accessed October 25, 2011.</div><br><div id="R23">23.

Gazzaruso&nbsp;C, Coppola&nbsp;A, Montalcini&nbsp;T, Valenti&nbsp;C, Garzaniti&nbsp;A, Pelissero&nbsp;G, et al.

<article-title xmlns:oasis="http://docs.oasis-open.org/ns/oasis-exchange/table">Erectile dysfunction can improve the effectiveness of the current guidelines for the screening for asymptomatic coronary artery disease in diabetes</article-title>.

Endocrine&nbsp;2011;

40:273-9; PMID:&nbsp;<a href="http://www.ncbi.nlm.nih.gov/pubmed/21861245" target="_blank">21861245</a>; DOI:&nbsp;<a href="http://dx.doi.org/10.1007/s12020-011-9523-9" target="_blank">10.1007/s12020-011-9523-9</a>.

</div><br><div id="R24">24.

Salem&nbsp;S, Abdi&nbsp;S, Mehrsai&nbsp;A, Saboury&nbsp;B, Saraji&nbsp;A, Shokohideh&nbsp;V, et al.

<article-title xmlns:oasis="http://docs.oasis-open.org/ns/oasis-exchange/table">Erectile dysfunction severity as a risk predictor for coronary artery disease</article-title>.

J Sex Med&nbsp;2009;

6:3425-32; PMID:&nbsp;<a href="http://www.ncbi.nlm.nih.gov/pubmed/19796020" target="_blank">19796020</a>; DOI:&nbsp;<a href="http://dx.doi.org/10.1111/j.1743-6109.2009.01515.x" target="_blank">10.1111/j.1743-6109.2009.01515.x</a>.

</div><br><div id="R25">25.

Billups&nbsp;KL, Bank&nbsp;AJ, Padma-Nathan&nbsp;H, Katz&nbsp;S, Williams&nbsp;R.

<article-title xmlns:oasis="http://docs.oasis-open.org/ns/oasis-exchange/table">Erectile dysfunction is a marker for cardiovascular disease: results of the minority health institute expert advisory panel</article-title>.

J Sex Med&nbsp;2005;

2:40-50, discussion 50-2; PMID:&nbsp;<a href="http://www.ncbi.nlm.nih.gov/pubmed/16422903" target="_blank">16422903</a>; DOI:&nbsp;<a href="http://dx.doi.org/10.1111/j.1743-6109.2005.20104_1.x" target="_blank">10.1111/j.1743-6109.2005.20104_1.x</a>.

</div><br><div id="R26">26.

Jackson&nbsp;G, Boon&nbsp;N, Eardley&nbsp;I, Kirby&nbsp;M, Dean&nbsp;J, Hackett&nbsp;G, et al.

<article-title xmlns:oasis="http://docs.oasis-open.org/ns/oasis-exchange/table">Erectile dysfunction and coronary artery disease prediction: evidence-based guidance and consensus</article-title>.

Int J Clin Pract&nbsp;2010;

64:848-57; PMID:&nbsp;<a href="http://www.ncbi.nlm.nih.gov/pubmed/20584218" target="_blank">20584218</a>; DOI:&nbsp;<a href="http://dx.doi.org/10.1111/j.1742-1241.2010.02410.x" target="_blank">10.1111/j.1742-1241.2010.02410.x</a>.

</div><br><div id="R27">27.

Polonsky&nbsp;TS, Taillon&nbsp;LA, Sheth&nbsp;H, Min&nbsp;JK, Archer&nbsp;SL, Ward&nbsp;RP.

<article-title xmlns:oasis="http://docs.oasis-open.org/ns/oasis-exchange/table">The association between erectile dysfunction and peripheral arterial disease as determined by screening ankle-brachial index testing</article-title>.

Atherosclerosis&nbsp;2009;

207:440-4; PMID:&nbsp;<a href="http://www.ncbi.nlm.nih.gov/pubmed/19501825" target="_blank">19501825</a>; DOI:&nbsp;<a href="http://dx.doi.org/10.1016/j.atherosclerosis.2009.05.005" target="_blank">10.1016/j.atherosclerosis.2009.05.005</a>.

</div><br><div id="R28">28.

Böhm&nbsp;M, Baumhäkel&nbsp;M, Teo&nbsp;K, Sleight&nbsp;P, Probstfield&nbsp;J, Gao&nbsp;P, et al.

<article-title xmlns:oasis="http://docs.oasis-open.org/ns/oasis-exchange/table">Erectile dysfunction predicts cardiovascular events in high-risk patients receiving telmisartan, ramipril, or both: The ONgoing Telmisartan Alone and in combination with Ramipril Global Endpoint Trial/Telmisartan Randomized AssessmeNt Study in ACE iNtolerant subjects with cardiovascular Disease (ONTARGET/TRANSCEND) Trials</article-title>.

Circulation&nbsp;2010;

121:1439-46; PMID:&nbsp;<a href="http://www.ncbi.nlm.nih.gov/pubmed/20231536" target="_blank">20231536</a>; DOI:&nbsp;<a href="http://dx.doi.org/10.1161/CIRCULATIONAHA.109.864199" target="_blank">10.1161/CIRCULATIONAHA.109.864199</a>.

</div><br><div id="R29">29.

Los Angeles Times Online. March 16, 2010. http://articles.latimes.com/2010/mar/16/science/la-sci-ed-heart16-2010 Mar16 Accessed October 26, 2011.</div><br><div id="R30">30.

Fung&nbsp;MM, Bettencourt&nbsp;R, Barrett-Connor&nbsp;E.

<article-title xmlns:oasis="http://docs.oasis-open.org/ns/oasis-exchange/table">Heart disease risk factors predict erectile dysfunction 25 years later: the Rancho Bernardo Study</article-title>.

J Am Coll Cardiol&nbsp;2004;

43:1405-11; PMID:&nbsp;<a href="http://www.ncbi.nlm.nih.gov/pubmed/15093875" target="_blank">15093875</a>; DOI:&nbsp;<a href="http://dx.doi.org/10.1016/j.jacc.2003.11.041" target="_blank">10.1016/j.jacc.2003.11.041</a>.

</div><br><div id="R31">31.

Gupta&nbsp;BP, Murad&nbsp;MH, Clifton&nbsp;MM, Prokop&nbsp;L, Nehra&nbsp;A, Kopecky&nbsp;SL.

<article-title xmlns:oasis="http://docs.oasis-open.org/ns/oasis-exchange/table">The effect of lifestyle modification and cardiovascular risk factor reduction on erectile dysfunction: a systematic review and meta-analysis</article-title>.

Arch Intern Med&nbsp;2011;

171:1797-803; PMID:&nbsp;<a href="http://www.ncbi.nlm.nih.gov/pubmed/21911624" target="_blank">21911624</a>; DOI:&nbsp;<a href="http://dx.doi.org/10.1001/archinternmed.2011.440" target="_blank">10.1001/archinternmed.2011.440</a>.

</div><br><div id="R32">32.

Makariou&nbsp;SE, Liberopoulos&nbsp;EN, Agouridis&nbsp;AP, Challa&nbsp;A, Elisaf&nbsp;M.

<article-title xmlns:oasis="http://docs.oasis-open.org/ns/oasis-exchange/table">Effect of Rosuvastatin Monotherapy and in Combination With Fenofibrate or Omega-3 Fatty Acids on Serum Vitamin D Levels</article-title>.

J Cardiovasc Pharmacol Ther&nbsp;2012;

; PMID:&nbsp;<a href="http://www.ncbi.nlm.nih.gov/pubmed/22431864" target="_blank">22431864</a>; DOI:&nbsp;<a href="http://dx.doi.org/10.1177/1074248412439470" target="_blank">10.1177/1074248412439470</a>.

</div><br><div id="R33">33.

Al Mheid&nbsp;I, Patel&nbsp;R, Murrow&nbsp;J, Morris&nbsp;A, Rahman&nbsp;A, Fike&nbsp;L, et al.

<article-title xmlns:oasis="http://docs.oasis-open.org/ns/oasis-exchange/table">Vitamin D status is associated with arterial stiffness and vascular dysfunction in healthy humans</article-title>.

J Am Coll Cardiol&nbsp;2011;

58:186-92; PMID:&nbsp;<a href="http://www.ncbi.nlm.nih.gov/pubmed/21718915" target="_blank">21718915</a>; DOI:&nbsp;<a href="http://dx.doi.org/10.1016/j.jacc.2011.02.051" target="_blank">10.1016/j.jacc.2011.02.051</a>.

</div><br><div id="R34">34.

Jablonski&nbsp;KL, Chonchol&nbsp;M, Pierce&nbsp;GL, Walker&nbsp;AE, Seals&nbsp;DR.

<article-title xmlns:oasis="http://docs.oasis-open.org/ns/oasis-exchange/table">25-Hydroxyvitamin D deficiency is associated with inflammation-linked vascular endothelial dysfunction in middle-aged and older adults</article-title>.

Hypertension&nbsp;2011;

57:63-9; PMID:&nbsp;<a href="http://www.ncbi.nlm.nih.gov/pubmed/21115878" target="_blank">21115878</a>; DOI:&nbsp;<a href="http://dx.doi.org/10.1161/HYPERTENSIONAHA.110.160929" target="_blank">10.1161/HYPERTENSIONAHA.110.160929</a>.

</div><br><div id="R35">35.

Vacek&nbsp;JL, Vanga&nbsp;SR, Good&nbsp;M, Lai&nbsp;SM, Lakkireddy&nbsp;D, Howard&nbsp;PA.

<article-title xmlns:oasis="http://docs.oasis-open.org/ns/oasis-exchange/table">Vitamin D deficiency and supplementation and relation to cardiovascular health</article-title>.

Am J Cardiol&nbsp;2012;

109:359-63; PMID:&nbsp;<a href="http://www.ncbi.nlm.nih.gov/pubmed/22071212" target="_blank">22071212</a>; DOI:&nbsp;<a href="http://dx.doi.org/10.1016/j.amjcard.2011.09.020" target="_blank">10.1016/j.amjcard.2011.09.020</a>.

</div><br><div id="R36">36.

Giovannucci&nbsp;E, Liu&nbsp;Y, Hollis&nbsp;BW, Rimm&nbsp;EB.

<article-title xmlns:oasis="http://docs.oasis-open.org/ns/oasis-exchange/table">25-hydroxy-vitamin D and risk of myocardial infarction in men</article-title>.

Ann Intern Med&nbsp;2008;

168:1174-80; DOI:&nbsp;<a href="http://dx.doi.org/10.1001/archinte.168.11.1174" target="_blank">10.1001/archinte.168.11.1174</a>.

</div><br><div id="R37">37.

Watson&nbsp;KE, Abrolat&nbsp;ML, Malone&nbsp;LL, Hoeg&nbsp;JM, Doherty&nbsp;T, Detrano&nbsp;R, et al.

<article-title xmlns:oasis="http://docs.oasis-open.org/ns/oasis-exchange/table">Active serum vitamin D levels are inversely correlated with coronary calcification</article-title>.

Circulation&nbsp;1997;

96:1755-60; PMID:&nbsp;<a href="http://www.ncbi.nlm.nih.gov/pubmed/9323058" target="_blank">9323058</a>.

</div><br><div id="R38">38.

Beadenkopf&nbsp;WG, Daoud&nbsp;AS, Love&nbsp;BM.

<article-title xmlns:oasis="http://docs.oasis-open.org/ns/oasis-exchange/table">Calcification in the coronary arteries and its relationship to arteriosclerosis and myocardial infarction</article-title>.

Am J Roentgenol Radium Ther Nucl Med&nbsp;1964;

92:865-71; PMID:&nbsp;<a href="http://www.ncbi.nlm.nih.gov/pubmed/14215099" target="_blank">14215099</a>.

</div><br><div id="R39">39.

Agatston&nbsp;AS, Janowitz&nbsp;WR, Hildner&nbsp;FJ, Zusmer&nbsp;NR, Viamonte&nbsp;M, Detrano&nbsp;R.

<article-title xmlns:oasis="http://docs.oasis-open.org/ns/oasis-exchange/table">Quantification of coronary artery calcium using ultrafast computed tomography</article-title>.

J Am Coll Cardiol&nbsp;1990;

15:827-32; PMID:&nbsp;<a href="http://www.ncbi.nlm.nih.gov/pubmed/2407762" target="_blank">2407762</a>; DOI:&nbsp;<a href="http://dx.doi.org/10.1016/0735-1097(90)90282-T" target="_blank">10.1016/0735-1097(90)90282-T</a>.

</div><br><div id="R40">40.

Feldman&nbsp;C, Vitola&nbsp;D, Schiavo&nbsp;N.

<article-title xmlns:oasis="http://docs.oasis-open.org/ns/oasis-exchange/table">Detection of coronary artery disease based on the calcification index obtained by helical computed tomography</article-title>.

Arq Bras Cardiol&nbsp;2000;

75:471-80; PMID:&nbsp;<a href="http://www.ncbi.nlm.nih.gov/pubmed/11175472" target="_blank">11175472</a>; DOI:&nbsp;<a href="http://dx.doi.org/10.1590/S0066-782X2000001200002" target="_blank">10.1590/S0066-782X2000001200002</a>.

</div><br><div id="R41">41.

Kitamura&nbsp;A, Kobayashi&nbsp;T, Ueda&nbsp;K, Okada&nbsp;T, Awata&nbsp;N, Sato&nbsp;S, et al.

<article-title xmlns:oasis="http://docs.oasis-open.org/ns/oasis-exchange/table">Evaluation of coronary artery calcification by multi-detector row computed tomography for the detection of coronary artery stenosis in Japanese patients</article-title>.

J Epidemiol&nbsp;2005;

15:187-93; PMID:&nbsp;<a href="http://www.ncbi.nlm.nih.gov/pubmed/16195639" target="_blank">16195639</a>; DOI:&nbsp;<a href="http://dx.doi.org/10.2188/jea.15.187" target="_blank">10.2188/jea.15.187</a>.

</div><br><div id="R42">42.

Santos&nbsp;RD, Rumberger&nbsp;JA, Budoff&nbsp;MJ, Shaw&nbsp;LJ, Orakzai&nbsp;SH, Berman&nbsp;D, et al.

<article-title xmlns:oasis="http://docs.oasis-open.org/ns/oasis-exchange/table">Thoracic aorta calcification detected by electron beam tomography predicts all-cause mortality</article-title>.

Atherosclerosis&nbsp;2010;

209:131-5.

</div><br><div id="R43">43.

Jacobs&nbsp;PC, Prokop&nbsp;M, van der Graaf&nbsp;Y, Gondrie&nbsp;MJ, Janssen&nbsp;KJ, de Koning&nbsp;HJ, et al.

<article-title xmlns:oasis="http://docs.oasis-open.org/ns/oasis-exchange/table">Comparing coronary artery calcium and thoracic aorta calcium for prediction of all-cause mortality and cardiovascular events on low-dose non-gated computed tomography in a high-risk population of heavy smokers</article-title>.

Atherosclerosis&nbsp;2010;

209:455-62; PMID:&nbsp;<a href="http://www.ncbi.nlm.nih.gov/pubmed/19875116" target="_blank">19875116</a>; DOI:&nbsp;<a href="http://dx.doi.org/10.1016/j.atherosclerosis.2009.09.031" target="_blank">10.1016/j.atherosclerosis.2009.09.031</a>.

</div><br><div id="R44">44.

Lee&nbsp;JH, Ngengwe&nbsp;R, Jones&nbsp;P, Tang&nbsp;F, O’Keefe&nbsp;JH.

<article-title xmlns:oasis="http://docs.oasis-open.org/ns/oasis-exchange/table">Erectile dysfunction as a coronary artery disease risk equivalent</article-title>.

J Nucl Cardiol&nbsp;2008;

15:800-3; PMID:&nbsp;<a href="http://www.ncbi.nlm.nih.gov/pubmed/18984455" target="_blank">18984455</a>.

</div><br><div id="R45">45.

Zittermann&nbsp;A, Schleithoff&nbsp;SS, Koerfer&nbsp;R.

<article-title xmlns:oasis="http://docs.oasis-open.org/ns/oasis-exchange/table">Vitamin D and vascular calcification</article-title>.

Curr Opin Lipidol&nbsp;2007;

18:41-6; PMID:&nbsp;<a href="http://www.ncbi.nlm.nih.gov/pubmed/17218831" target="_blank">17218831</a>; DOI:&nbsp;<a href="http://dx.doi.org/10.1097/MOL.0b013e328011c6fc" target="_blank">10.1097/MOL.0b013e328011c6fc</a>.

</div><br><div id="R46">46.

National Diabetes Fact Sheet. 2007. Available at http://www.cdc.gov/diabetes/pubs/pdf/ndfs_2007.pdf. Accessed November 25, 2011.</div><br><div id="R47">47.

Franco&nbsp;OH, Steyerberg&nbsp;EW, Hu&nbsp;FB, Mackenbach&nbsp;J, Nusselder&nbsp;W.

<article-title xmlns:oasis="http://docs.oasis-open.org/ns/oasis-exchange/table">Associations of diabetes mellitus with total life expectancy and life expectancy with and without cardiovascular disease</article-title>.

Arch Intern Med&nbsp;2007;

167:1145-51; PMID:&nbsp;<a href="http://www.ncbi.nlm.nih.gov/pubmed/17563022" target="_blank">17563022</a>; DOI:&nbsp;<a href="http://dx.doi.org/10.1001/archinte.167.11.1145" target="_blank">10.1001/archinte.167.11.1145</a>.

</div><br><div id="R48">48.

Fox&nbsp;CS, Pencina&nbsp;MJ, Meigs&nbsp;JB, Vasan&nbsp;RS, Levitzky&nbsp;YS, D’Agostino&nbsp;RB.

<article-title xmlns:oasis="http://docs.oasis-open.org/ns/oasis-exchange/table">Trends in the incidence of type 2 diabetes mellitus from the 1970s to the 1990s: the Framingham Heart Study</article-title>.

Circulation&nbsp;2006;

113:2914-8; PMID:&nbsp;<a href="http://www.ncbi.nlm.nih.gov/pubmed/16785337" target="_blank">16785337</a>; DOI:&nbsp;<a href="http://dx.doi.org/10.1161/CIRCULATIONAHA.106.613828" target="_blank">10.1161/CIRCULATIONAHA.106.613828</a>.

</div><br><div id="R49">49.

Fang&nbsp;J, Alderman&nbsp;MH.

<article-title xmlns:oasis="http://docs.oasis-open.org/ns/oasis-exchange/table">Impact of the increasing burden of diabetes on acute myocardial infarction in New York City: 1990-2000</article-title>.

Diabetes&nbsp;2006;

55:768-73; PMID:&nbsp;<a href="http://www.ncbi.nlm.nih.gov/pubmed/16505241" target="_blank">16505241</a>; DOI:&nbsp;<a href="http://dx.doi.org/10.2337/diabetes.55.03.06.db05-1196" target="_blank">10.2337/diabetes.55.03.06.db05-1196</a>.

</div><br><div id="R50">50.

Tousoulis&nbsp;D, Kampoli&nbsp;AM, Stefanadis&nbsp;C.

<article-title xmlns:oasis="http://docs.oasis-open.org/ns/oasis-exchange/table">Diabetes mellitus and vascular endothelial dysfunction: current perspectives</article-title>.

Curr Vasc Pharmacol&nbsp;2012;

10:19-32; PMID:&nbsp;<a href="http://www.ncbi.nlm.nih.gov/pubmed/22112354" target="_blank">22112354</a>; DOI:&nbsp;<a href="http://dx.doi.org/10.2174/157016112798829797" target="_blank">10.2174/157016112798829797</a>.

</div><br><div id="R51">51.

De Vriese&nbsp;AS, Verbeuren&nbsp;TJ, Van de Voorde&nbsp;J, Lameire&nbsp;NH, Vanhoutte&nbsp;PM.

<article-title xmlns:oasis="http://docs.oasis-open.org/ns/oasis-exchange/table">Endothelial dysfunction in diabetes</article-title>.

Br J Pharmacol&nbsp;2000;

130:963-74; PMID:&nbsp;<a href="http://www.ncbi.nlm.nih.gov/pubmed/10882379" target="_blank">10882379</a>; DOI:&nbsp;<a href="http://dx.doi.org/10.1038/sj.bjp.0703393" target="_blank">10.1038/sj.bjp.0703393</a>.

</div><br><div id="R52">52.

Williams&nbsp;SB, Cusco&nbsp;JA, Roddy&nbsp;MA, Johnstone&nbsp;MT, Creager&nbsp;MA.

<article-title xmlns:oasis="http://docs.oasis-open.org/ns/oasis-exchange/table">Impaired n<b>i</b>tric oxide-mediated vasodilation in patients with non-insulin-dependent diabetes mellitus</article-title>.

J Am Coll Cardiol&nbsp;1996;

27:567-74; PMID:&nbsp;<a href="http://www.ncbi.nlm.nih.gov/pubmed/8606266" target="_blank">8606266</a>; DOI:&nbsp;<a href="http://dx.doi.org/10.1016/0735-1097(95)00522-6" target="_blank">10.1016/0735-1097(95)00522-6</a>.

</div><br><div id="R53">53.

Beckman&nbsp;JA, Creager&nbsp;MA, Libby&nbsp;P.

<article-title xmlns:oasis="http://docs.oasis-open.org/ns/oasis-exchange/table">Diabetes and atherosclerosis: epidemiology, pathophysiology, and management</article-title>.

JAMA&nbsp;2002;

287:2570-81; PMID:&nbsp;<a href="http://www.ncbi.nlm.nih.gov/pubmed/12020339" target="_blank">12020339</a>; DOI:&nbsp;<a href="http://dx.doi.org/10.1001/jama.287.19.2570" target="_blank">10.1001/jama.287.19.2570</a>.

</div><br><div id="R54">54.

Awad&nbsp;H, Salem&nbsp;A, Gadalla&nbsp;A, El Wafa&nbsp;NA, Mohamed&nbsp;OA.

<article-title xmlns:oasis="http://docs.oasis-open.org/ns/oasis-exchange/table">Erectile function in men with diabetes type 2: correlation with glycemic control</article-title>.

Int J Impot Res&nbsp;2010;

22:36-9; PMID:&nbsp;<a href="http://www.ncbi.nlm.nih.gov/pubmed/19759543" target="_blank">19759543</a>; DOI:&nbsp;<a href="http://dx.doi.org/10.1038/ijir.2009.39" target="_blank">10.1038/ijir.2009.39</a>.

</div><br><div id="R55">55.

You&nbsp;RX, McNeil&nbsp;JJ, O’Malley&nbsp;HM, Davis&nbsp;SM, Thrift&nbsp;AG, Donnan&nbsp;GA.

<article-title xmlns:oasis="http://docs.oasis-open.org/ns/oasis-exchange/table">Risk factors for stroke due to cerebral infarction in young adults</article-title>.

Stroke&nbsp;1997;

28:1913-8; PMID:&nbsp;<a href="http://www.ncbi.nlm.nih.gov/pubmed/9341695" target="_blank">9341695</a>; DOI:&nbsp;<a href="http://dx.doi.org/10.1161/01.STR.28.10.1913" target="_blank">10.1161/01.STR.28.10.1913</a>.

</div><br><div id="R56">56.

Phé&nbsp;V, Rouprêt&nbsp;M.

<article-title xmlns:oasis="http://docs.oasis-open.org/ns/oasis-exchange/table">Erectile dysfunction and diabetes: a review of the current evidence-based medicine and a synthesis of the main available therapies</article-title>.

Diabetes Metab&nbsp;2012;

38:1-13; PMID:&nbsp;<a href="http://www.ncbi.nlm.nih.gov/pubmed/22056307" target="_blank">22056307</a>; DOI:&nbsp;<a href="http://dx.doi.org/10.1016/j.diabet.2011.09.003" target="_blank">10.1016/j.diabet.2011.09.003</a>.

</div><br><div id="R57">57.

Selvin&nbsp;E, Burnett&nbsp;AL, Platz&nbsp;EA.

<article-title xmlns:oasis="http://docs.oasis-open.org/ns/oasis-exchange/table">Prevalence and risk factors for erectile dysfunction in the US</article-title>.

Am J Med&nbsp;2007;

120:151-7; PMID:&nbsp;<a href="http://www.ncbi.nlm.nih.gov/pubmed/17275456" target="_blank">17275456</a>; DOI:&nbsp;<a href="http://dx.doi.org/10.1016/j.amjmed.2006.06.010" target="_blank">10.1016/j.amjmed.2006.06.010</a>.

</div><br><div id="R58">58.

Martin-Morales&nbsp;A, Sanchez-Cruz&nbsp;JJ, Saenz de Tejada&nbsp;I, Rodriguez-Vela&nbsp;L, Jimenez-Cruz&nbsp;JF, Burgos-Rodriguez&nbsp;R.

<article-title xmlns:oasis="http://docs.oasis-open.org/ns/oasis-exchange/table">Prevalence and independent risk factors for erectile dysfunction in Spain: results of the Epidemiologia de la Disfuncion Erectil Masculina Study</article-title>.

J Urol&nbsp;2001;

166:569-74, discussion 574-5; PMID:&nbsp;<a href="http://www.ncbi.nlm.nih.gov/pubmed/11458070" target="_blank">11458070</a>; DOI:&nbsp;<a href="http://dx.doi.org/10.1016/S0022-5347(05)65986-1" target="_blank">10.1016/S0022-5347(05)65986-1</a>.

</div><br><div id="R59">59.

Malavige&nbsp;LS, Levy&nbsp;JC.

<article-title xmlns:oasis="http://docs.oasis-open.org/ns/oasis-exchange/table">Erectile dysfunction in diabetes mellitus</article-title>.

J Sex Med&nbsp;2009;

6:1232-47; PMID:&nbsp;<a href="http://www.ncbi.nlm.nih.gov/pubmed/19210706" target="_blank">19210706</a>; DOI:&nbsp;<a href="http://dx.doi.org/10.1111/j.1743-6109.2008.01168.x" target="_blank">10.1111/j.1743-6109.2008.01168.x</a>.

</div><br><div id="R60">60.

Feldman&nbsp;HA, Goldstein&nbsp;I, Hatzichristou&nbsp;DG, Krane&nbsp;RJ, McKinlay&nbsp;JB.

<article-title xmlns:oasis="http://docs.oasis-open.org/ns/oasis-exchange/table">Impotence and its medical and psychosocial correlates: results of the Massachusetts Male Aging Study</article-title>.

J Urol&nbsp;1994;

151:54-61; PMID:&nbsp;<a href="http://www.ncbi.nlm.nih.gov/pubmed/8254833" target="_blank">8254833</a>.

</div><br><div id="R61">61.

Ishii&nbsp;H, Suzuki&nbsp;H, Baba&nbsp;T, Nakamura&nbsp;K, Watanabe&nbsp;T.

<article-title xmlns:oasis="http://docs.oasis-open.org/ns/oasis-exchange/table">Seasonal variation of glycemic control in type 2 diabetic patients</article-title>.

Diabetes Care&nbsp;2001;

24:1503; PMID:&nbsp;<a href="http://www.ncbi.nlm.nih.gov/pubmed/11473100" target="_blank">11473100</a>; DOI:&nbsp;<a href="http://dx.doi.org/10.2337/diacare.24.8.1503" target="_blank">10.2337/diacare.24.8.1503</a>.

</div><br><div id="R62">62.

Colas&nbsp;C, Garabedian&nbsp;M, Fontbonne&nbsp;A, Guillozo&nbsp;H, Slama&nbsp;G, Desplanque&nbsp;N, et al.

<article-title xmlns:oasis="http://docs.oasis-open.org/ns/oasis-exchange/table">Insulin secretion and plasma 1,25-(OH)2D after UV-B irradiation in healthy adults</article-title>.

Horm Metab Res&nbsp;1989;

21:154-5; PMID:&nbsp;<a href="http://www.ncbi.nlm.nih.gov/pubmed/2663692" target="_blank">2663692</a>; DOI:&nbsp;<a href="http://dx.doi.org/10.1055/s-2007-1009178" target="_blank">10.1055/s-2007-1009178</a>.

</div><br><div id="R63">63.

Pittas&nbsp;AG, Harris&nbsp;SS, Stark&nbsp;PC, Dawson-Hughes&nbsp;B.

<article-title xmlns:oasis="http://docs.oasis-open.org/ns/oasis-exchange/table">The effects of calcium and vitamin D supplementation on blood glucose and markers of inflammation in nondiabetic adults</article-title>.

Diabetes Care&nbsp;2007;

30:980-6; PMID:&nbsp;<a href="http://www.ncbi.nlm.nih.gov/pubmed/17277040" target="_blank">17277040</a>; DOI:&nbsp;<a href="http://dx.doi.org/10.2337/dc06-1994" target="_blank">10.2337/dc06-1994</a>.

</div><br><div id="R64">64.

Nazarian&nbsp;S, St Peter&nbsp;JV, Boston&nbsp;RC, Jones&nbsp;SA, Mariash&nbsp;CN.

<article-title xmlns:oasis="http://docs.oasis-open.org/ns/oasis-exchange/table">Vitamin D3 supplementation improves insulin sensitivity in subjects with impaired fasting glucose</article-title>.

Transl Res&nbsp;2011;

158:276-81; PMID:&nbsp;<a href="http://www.ncbi.nlm.nih.gov/pubmed/22005267" target="_blank">22005267</a>; DOI:&nbsp;<a href="http://dx.doi.org/10.1016/j.trsl.2011.05.002" target="_blank">10.1016/j.trsl.2011.05.002</a>.

</div><br><div id="R65">65.

Mitri&nbsp;J, Dawson-Hughes&nbsp;B, Hu&nbsp;FB, Pittas&nbsp;AG.

<article-title xmlns:oasis="http://docs.oasis-open.org/ns/oasis-exchange/table">Effects of vitamin D and calcium supplementation on pancreatic ? cell function, insulin sensitivity, and glycemia in adults at high risk of diabetes: the Calcium and Vitamin D for Diabetes Mellitus (CaDDM) randomized controlled trial</article-title>.

Am J Clin Nutr&nbsp;2011;

94:486-94; PMID:&nbsp;<a href="http://www.ncbi.nlm.nih.gov/pubmed/21715514" target="_blank">21715514</a>; DOI:&nbsp;<a href="http://dx.doi.org/10.3945/ajcn.111.011684" target="_blank">10.3945/ajcn.111.011684</a>.

</div><br><div id="R66">66.

Bowman&nbsp;TS, Sesso&nbsp;HD, Gaziano&nbsp;JM.

<article-title xmlns:oasis="http://docs.oasis-open.org/ns/oasis-exchange/table">Effect of age on blood pressure parameters and risk of cardiovascular death in men</article-title>.

Am J Hypertens&nbsp;2006;

19:47-52; PMID:&nbsp;<a href="http://www.ncbi.nlm.nih.gov/pubmed/16461190" target="_blank">16461190</a>; DOI:&nbsp;<a href="http://dx.doi.org/10.1016/j.amjhyper.2005.06.024" target="_blank">10.1016/j.amjhyper.2005.06.024</a>.

</div><br><div id="R67">67.

Gu&nbsp;D, Kelly&nbsp;TN, Wu&nbsp;X, Chen&nbsp;J, Duan&nbsp;X, Huang&nbsp;JF, et al.

<article-title xmlns:oasis="http://docs.oasis-open.org/ns/oasis-exchange/table">Blood pressure and risk of cardiovascular disease in Chinese men and women</article-title>.

Am J Hypertens&nbsp;2008;

21:265-72; PMID:&nbsp;<a href="http://www.ncbi.nlm.nih.gov/pubmed/18188156" target="_blank">18188156</a>; DOI:&nbsp;<a href="http://dx.doi.org/10.1038/ajh.2007.59" target="_blank">10.1038/ajh.2007.59</a>.

</div><br><div id="R68">68.

Sanford School of Medicine, Stanford Stroke Center. Available online at http://strokecenter.stanford.edu/guide/prevention.html. Accessed Nov 30, 2011.</div><br><div id="R69">69.

Sacco&nbsp;RL, Benjamin&nbsp;EJ, Broderick&nbsp;JP, Dyken&nbsp;M, Easton&nbsp;JD, Feinberg&nbsp;WM.

<article-title xmlns:oasis="http://docs.oasis-open.org/ns/oasis-exchange/table">Risk factors</article-title>.

Stroke&nbsp;1997;

38:1507-17.

</div><br><div id="R70">70.

Manolis&nbsp;A, Doumas&nbsp;M.

<article-title xmlns:oasis="http://docs.oasis-open.org/ns/oasis-exchange/table">Sexual dysfunction: the ‘prima ballerina’ of hypertension-related quality-of-life complications</article-title>.

J Hypertens&nbsp;2008;

26:2074-84; PMID:&nbsp;<a href="http://www.ncbi.nlm.nih.gov/pubmed/18854743" target="_blank">18854743</a>; DOI:&nbsp;<a href="http://dx.doi.org/10.1097/HJH.0b013e32830dd0c6" target="_blank">10.1097/HJH.0b013e32830dd0c6</a>.

</div><br><div id="R71">71.

Burchardt&nbsp;M, Burchardt&nbsp;T, Baer&nbsp;L, Kiss&nbsp;AJ, Pawar&nbsp;RV, Shabsigh&nbsp;A, et al.

<article-title xmlns:oasis="http://docs.oasis-open.org/ns/oasis-exchange/table">Hypertension is associated with severe erectile dysfunction</article-title>.

J Urol&nbsp;2000;

164:1188-91; PMID:&nbsp;<a href="http://www.ncbi.nlm.nih.gov/pubmed/10992363" target="_blank">10992363</a>; DOI:&nbsp;<a href="http://dx.doi.org/10.1016/S0022-5347(05)67138-8" target="_blank">10.1016/S0022-5347(05)67138-8</a>.

</div><br><div id="R72">72.

Giuliano&nbsp;FA, Leriche&nbsp;A, Jaudinot&nbsp;EO, de Gendre&nbsp;AS.

<article-title xmlns:oasis="http://docs.oasis-open.org/ns/oasis-exchange/table">Prevalence of erectile dysfunction among 7689 patients with diabetes or hypertension, or both</article-title>.

Urology&nbsp;2004;

64:1196-201; PMID:&nbsp;<a href="http://www.ncbi.nlm.nih.gov/pubmed/15596196" target="_blank">15596196</a>; DOI:&nbsp;<a href="http://dx.doi.org/10.1016/j.urology.2004.08.059" target="_blank">10.1016/j.urology.2004.08.059</a>.

</div><br><div id="R73">73.

Chung&nbsp;SD, Chen&nbsp;YK, Lin&nbsp;HC, Lin&nbsp;HC.

<article-title xmlns:oasis="http://docs.oasis-open.org/ns/oasis-exchange/table">Increased risk of stroke among men with erectile dysfunction: a nationwide population-based study</article-title>.

J Sex Med&nbsp;2011;

8:240-6; PMID:&nbsp;<a href="http://www.ncbi.nlm.nih.gov/pubmed/20722781" target="_blank">20722781</a>; DOI:&nbsp;<a href="http://dx.doi.org/10.1111/j.1743-6109.2010.01973.x" target="_blank">10.1111/j.1743-6109.2010.01973.x</a>.

</div><br><div id="R74">74.

Sigmund&nbsp;CD.

<article-title xmlns:oasis="http://docs.oasis-open.org/ns/oasis-exchange/table">Regulation of renin expression and blood pressure by vitamin D(3)</article-title>.

J Clin Invest&nbsp;2002;

110:155-6; PMID:&nbsp;<a href="http://www.ncbi.nlm.nih.gov/pubmed/12122105" target="_blank">12122105</a>.

</div><br><div id="R75">75.

Li&nbsp;YC, Qiao&nbsp;G, Uskokovic&nbsp;M, Xiang&nbsp;W, Zheng&nbsp;W, Kong&nbsp;J.

<article-title xmlns:oasis="http://docs.oasis-open.org/ns/oasis-exchange/table">Vitamin D: a negative endocrine regulator of the renin-angiotensin system and blood pressure</article-title>.

J Steroid Biochem Mol Biol&nbsp;2004;

89-90:387-92; PMID:&nbsp;<a href="http://www.ncbi.nlm.nih.gov/pubmed/15225806" target="_blank">15225806</a>; DOI:&nbsp;<a href="http://dx.doi.org/10.1016/j.jsbmb.2004.03.004" target="_blank">10.1016/j.jsbmb.2004.03.004</a>.

</div><br><div id="R76">76.

Forman&nbsp;JP, Williams&nbsp;JS, Fisher&nbsp;ND.

<article-title xmlns:oasis="http://docs.oasis-open.org/ns/oasis-exchange/table">Plasma 25-hydroxyvitamin D and regulation of the renin-angiotensin system in humans</article-title>.

Hypertension&nbsp;2010;

55:1283-8; PMID:&nbsp;<a href="http://www.ncbi.nlm.nih.gov/pubmed/20351344" target="_blank">20351344</a>; DOI:&nbsp;<a href="http://dx.doi.org/10.1161/HYPERTENSIONAHA.109.148619" target="_blank">10.1161/HYPERTENSIONAHA.109.148619</a>.

</div><br><div id="R77">77.

Ullah&nbsp;MI, Uwaifo&nbsp;GI, Nicholas&nbsp;WC, Koch&nbsp;CA.

<article-title xmlns:oasis="http://docs.oasis-open.org/ns/oasis-exchange/table">Does vitamin d deficiency cause hypertension? Current evidence from clinical studies and potential mechanisms</article-title>.

Int J Endocrinol&nbsp;2010;

:579640.

</div><br><div id="R78">78.

Charach&nbsp;G, Rabinovich&nbsp;PD, Weintraub&nbsp;M.

<article-title xmlns:oasis="http://docs.oasis-open.org/ns/oasis-exchange/table">Seasonal changes in blood pressure and frequency of related complications in elderly Israeli patients with essential hypertension</article-title>.

Gerontology&nbsp;2004;

50:315-21; PMID:&nbsp;<a href="http://www.ncbi.nlm.nih.gov/pubmed/15331861" target="_blank">15331861</a>; DOI:&nbsp;<a href="http://dx.doi.org/10.1159/000079130" target="_blank">10.1159/000079130</a>.

</div><br><div id="R79">79.

Polat&nbsp;M, Akil&nbsp;I, Yuksel&nbsp;H, Coskun&nbsp;S, Yilmaz&nbsp;D, Erguder&nbsp;I, et al.

<article-title xmlns:oasis="http://docs.oasis-open.org/ns/oasis-exchange/table">The effect of seasonal changes on blood pressure and urine specific gravity in children living in Mediterranean climate</article-title>.

Med Sci Monit&nbsp;2006;

12:CR186-90; PMID:&nbsp;<a href="http://www.ncbi.nlm.nih.gov/pubmed/16572065" target="_blank">16572065</a>.

</div><br><div id="R80">80.

Krause&nbsp;R, Bühring&nbsp;M, Hopfenmüller&nbsp;W, Holick&nbsp;MF, Sharma&nbsp;AM.

<article-title xmlns:oasis="http://docs.oasis-open.org/ns/oasis-exchange/table">Ultraviolet B and blood pressure</article-title>.

Lancet&nbsp;1998;

352:709-10; PMID:&nbsp;<a href="http://www.ncbi.nlm.nih.gov/pubmed/9728997" target="_blank">9728997</a>; DOI:&nbsp;<a href="http://dx.doi.org/10.1016/S0140-6736(05)60827-6" target="_blank">10.1016/S0140-6736(05)60827-6</a>.

</div><br><div id="R81">81.

Opländer&nbsp;C, Volkmar&nbsp;CM, Paunel-Görgülü&nbsp;A, van Faassen&nbsp;EE, Heiss&nbsp;C, Kelm&nbsp;M, et al.

<article-title xmlns:oasis="http://docs.oasis-open.org/ns/oasis-exchange/table">Whole body UVA irradiation lowers systemic blood pressure by release of nitric oxide from intracutaneous photolabile nitric oxide derivates</article-title>.

Circ Res&nbsp;2009;

105:1031-40; PMID:&nbsp;<a href="http://www.ncbi.nlm.nih.gov/pubmed/19797169" target="_blank">19797169</a>; DOI:&nbsp;<a href="http://dx.doi.org/10.1161/CIRCRESAHA.109.207019" target="_blank">10.1161/CIRCRESAHA.109.207019</a>.

</div><br><div id="R82">82.

Forman&nbsp;JP, Giovannucci&nbsp;E, Holmes&nbsp;MD, Bischoff-Ferrari&nbsp;HA, Tworoger&nbsp;SS, Willett&nbsp;WC, et al.

<article-title xmlns:oasis="http://docs.oasis-open.org/ns/oasis-exchange/table">Plasma 25-hydroxyvitamin D levels and risk of incident hypertension</article-title>.

Hypertension&nbsp;2007;

49:1063-9; PMID:&nbsp;<a href="http://www.ncbi.nlm.nih.gov/pubmed/17372031" target="_blank">17372031</a>; DOI:&nbsp;<a href="http://dx.doi.org/10.1161/HYPERTENSIONAHA.107.087288" target="_blank">10.1161/HYPERTENSIONAHA.107.087288</a>.

</div><br><div id="R83">83.

Anderson&nbsp;JL, May&nbsp;HT, Horne&nbsp;BD, Bair&nbsp;TL, Hall&nbsp;NL, Carlquist&nbsp;JF, et al.

<article-title xmlns:oasis="http://docs.oasis-open.org/ns/oasis-exchange/table">Relation of vitamin D deficiency to cardiovascular risk factors, disease status, and incident events in a general healthcare population</article-title>.

Am J Cardiol&nbsp;2010;

106:963-8; PMID:&nbsp;<a href="http://www.ncbi.nlm.nih.gov/pubmed/20854958" target="_blank">20854958</a>; DOI:&nbsp;<a href="http://dx.doi.org/10.1016/j.amjcard.2010.05.027" target="_blank">10.1016/j.amjcard.2010.05.027</a>.

</div><br><div id="R84">84.

Trepels&nbsp;T, Zeiher&nbsp;AM, Fichtlscherer&nbsp;S.

<article-title xmlns:oasis="http://docs.oasis-open.org/ns/oasis-exchange/table">The endothelium and inflammation</article-title>.

Endothelium&nbsp;2006;

13:423-9; PMID:&nbsp;<a href="http://www.ncbi.nlm.nih.gov/pubmed/17169774" target="_blank">17169774</a>; DOI:&nbsp;<a href="http://dx.doi.org/10.1080/10623320601061862" target="_blank">10.1080/10623320601061862</a>.

</div><br><div id="R85">85.

Manabe&nbsp;I.

<article-title xmlns:oasis="http://docs.oasis-open.org/ns/oasis-exchange/table">Chronic inflammation links cardiovascular, metabolic and renal diseases</article-title>.

Circ J&nbsp;2011;

75:2739-48; PMID:&nbsp;<a href="http://www.ncbi.nlm.nih.gov/pubmed/22067929" target="_blank">22067929</a>; DOI:&nbsp;<a href="http://dx.doi.org/10.1253/circj.CJ-11-1184" target="_blank">10.1253/circj.CJ-11-1184</a>.

</div><br><div id="R86">86.

Libby&nbsp;P, Okamoto&nbsp;Y, Rocha&nbsp;VZ, Folco&nbsp;E.

<article-title xmlns:oasis="http://docs.oasis-open.org/ns/oasis-exchange/table">Inflammation in atherosclerosis: transition from theory to practice</article-title>.

Circ J&nbsp;2010;

74:213-20; PMID:&nbsp;<a href="http://www.ncbi.nlm.nih.gov/pubmed/20065609" target="_blank">20065609</a>; DOI:&nbsp;<a href="http://dx.doi.org/10.1253/circj.CJ-09-0706" target="_blank">10.1253/circj.CJ-09-0706</a>.

</div><br><div id="R87">87.

Libby&nbsp;P.

<article-title xmlns:oasis="http://docs.oasis-open.org/ns/oasis-exchange/table">Inflammation and cardiovascular disease mechanisms</article-title>.

Am J Clin Nutr&nbsp;2006;

83:456S-60S; PMID:&nbsp;<a href="http://www.ncbi.nlm.nih.gov/pubmed/16470012" target="_blank">16470012</a>.

</div><br><div id="R88">88.

Cybulsky&nbsp;MI, Gimbrone&nbsp;MA.

<article-title xmlns:oasis="http://docs.oasis-open.org/ns/oasis-exchange/table">Endothelial expression of a mononuclear leukocyte adhesion molecule during atherogenesis</article-title>.

Science&nbsp;1991;

251:788-91; PMID:&nbsp;<a href="http://www.ncbi.nlm.nih.gov/pubmed/1990440" target="_blank">1990440</a>; DOI:&nbsp;<a href="http://dx.doi.org/10.1126/science.1990440" target="_blank">10.1126/science.1990440</a>.

</div><br><div id="R89">89.

Li&nbsp;H, Cybulsky&nbsp;MI, Gimbrone&nbsp;MA, Libby&nbsp;P.

<article-title xmlns:oasis="http://docs.oasis-open.org/ns/oasis-exchange/table">Inducible expression of vascular cell adhesion molecule-1 by vascular smooth muscle cells in vitro and within rabbit atheroma</article-title>.

Am J Pathol&nbsp;1993;

143:1551-9; PMID:&nbsp;<a href="http://www.ncbi.nlm.nih.gov/pubmed/7504883" target="_blank">7504883</a>.

</div><br><div id="R90">90.

Gu&nbsp;L, Okada&nbsp;Y, Clinton&nbsp;SK, Gerard&nbsp;C, Sukhova&nbsp;GK, Libby&nbsp;P, et al.

<article-title xmlns:oasis="http://docs.oasis-open.org/ns/oasis-exchange/table">Absence of monocyte chemoattractant protein-1 reduces atherosclerosis in low density lipoprotein receptor-deficient mice</article-title>.

Mol Cell&nbsp;1998;

2:275-81; PMID:&nbsp;<a href="http://www.ncbi.nlm.nih.gov/pubmed/9734366" target="_blank">9734366</a>; DOI:&nbsp;<a href="http://dx.doi.org/10.1016/S1097-2765(00)80139-2" target="_blank">10.1016/S1097-2765(00)80139-2</a>.

</div><br><div id="R91">91.

Boring&nbsp;L, Gosling&nbsp;J, Cleary&nbsp;M, Charo&nbsp;IF.

<article-title xmlns:oasis="http://docs.oasis-open.org/ns/oasis-exchange/table">Decreased lesion formation in CCR2-/- mice reveals a role for chemokines in the initiation of atherosclerosis</article-title>.

Nature&nbsp;1998;

394:894-7; PMID:&nbsp;<a href="http://www.ncbi.nlm.nih.gov/pubmed/9732872" target="_blank">9732872</a>; DOI:&nbsp;<a href="http://dx.doi.org/10.1038/29788" target="_blank">10.1038/29788</a>.

</div><br><div id="R92">92.

Chiurlia&nbsp;E, D’Amico&nbsp;R, Ratti&nbsp;C, Granata&nbsp;AR, Romagnoli&nbsp;R, Modena&nbsp;MG.

<article-title xmlns:oasis="http://docs.oasis-open.org/ns/oasis-exchange/table">Subclinical coronary artery atherosclerosis in patients with erectile dysfunction</article-title>.

J Am Coll Cardiol&nbsp;2005;

46:1503-6; PMID:&nbsp;<a href="http://www.ncbi.nlm.nih.gov/pubmed/16226175" target="_blank">16226175</a>; DOI:&nbsp;<a href="http://dx.doi.org/10.1016/j.jacc.2005.06.068" target="_blank">10.1016/j.jacc.2005.06.068</a>.

</div><br><div id="R93">93.

Zambon&nbsp;JP, Mendonça&nbsp;RR, Wroclawski&nbsp;ML, Karam Junior&nbsp;A, Santos&nbsp;RD, Carvalho&nbsp;JA, et al.

<article-title xmlns:oasis="http://docs.oasis-open.org/ns/oasis-exchange/table">Cardiovascular and metabolic syndrome risk among men with and without erectile dysfunction: case-control study</article-title>.

Sao Paulo Med J&nbsp;2010;

128:137-40; PMID:&nbsp;<a href="http://www.ncbi.nlm.nih.gov/pubmed/20963365" target="_blank">20963365</a>; DOI:&nbsp;<a href="http://dx.doi.org/10.1590/S1516-31802010000300006" target="_blank">10.1590/S1516-31802010000300006</a>.

</div><br><div id="R94">94.

Verma&nbsp;S, Wang&nbsp;CH, Li&nbsp;SH, Dumont&nbsp;AS, Fedak&nbsp;PW, Badiwala&nbsp;MV, et al.

<article-title xmlns:oasis="http://docs.oasis-open.org/ns/oasis-exchange/table">A self-fulfilling prophecy: C-reactive protein attenuates nitric oxide production and inhibits angiogenesis</article-title>.

Circulation&nbsp;2002;

106:913-9; PMID:&nbsp;<a href="http://www.ncbi.nlm.nih.gov/pubmed/12186793" target="_blank">12186793</a>; DOI:&nbsp;<a href="http://dx.doi.org/10.1161/01.CIR.0000029802.88087.5E" target="_blank">10.1161/01.CIR.0000029802.88087.5E</a>.

</div><br><div id="R95">95.

Bocchio&nbsp;M, Desideri&nbsp;G, Scarpelli&nbsp;P, Necozione&nbsp;S, Properzi&nbsp;G, Spartera&nbsp;C, et al.

<article-title xmlns:oasis="http://docs.oasis-open.org/ns/oasis-exchange/table">Endothelial cell activation in men with erectile dysfunction without cardiovascular risk factors and overt vascular damage</article-title>.

J Urol&nbsp;2004;

171:1601-4; PMID:&nbsp;<a href="http://www.ncbi.nlm.nih.gov/pubmed/15017230" target="_blank">15017230</a>; DOI:&nbsp;<a href="http://dx.doi.org/10.1097/01.ju.0000116325.06572.85" target="_blank">10.1097/01.ju.0000116325.06572.85</a>.

</div><br><div id="R96">96.

Carneiro&nbsp;FS, Webb&nbsp;RC, Tostes&nbsp;RC.

<article-title xmlns:oasis="http://docs.oasis-open.org/ns/oasis-exchange/table">Emerging role for TNF-? in erectile dysfunction</article-title>.

J Sex Med&nbsp;2010;

7:3823-34; PMID:&nbsp;<a href="http://www.ncbi.nlm.nih.gov/pubmed/20345734" target="_blank">20345734</a>; DOI:&nbsp;<a href="http://dx.doi.org/10.1111/j.1743-6109.2010.01762.x" target="_blank">10.1111/j.1743-6109.2010.01762.x</a>.

</div><br><div id="R97">97.

Guillot&nbsp;X, Semerano&nbsp;L, Saidenberg-Kermanac’h&nbsp;N, Falgarone&nbsp;G, Boissier&nbsp;MC.

<article-title xmlns:oasis="http://docs.oasis-open.org/ns/oasis-exchange/table">Vitamin D and inflammation</article-title>.

Joint Bone Spine&nbsp;2010;

77:552-7; PMID:&nbsp;<a href="http://www.ncbi.nlm.nih.gov/pubmed/21067953" target="_blank">21067953</a>; DOI:&nbsp;<a href="http://dx.doi.org/10.1016/j.jbspin.2010.09.018" target="_blank">10.1016/j.jbspin.2010.09.018</a>.

</div><br><div id="R98">98.

Zittermann&nbsp;A, Schleithoff&nbsp;SS, Koerfer&nbsp;R.

<article-title xmlns:oasis="http://docs.oasis-open.org/ns/oasis-exchange/table">Putting cardiovascular disease and vitamin D insufficiency into perspective</article-title>.

Br J Nutr&nbsp;2005;

94:483-92; PMID:&nbsp;<a href="http://www.ncbi.nlm.nih.gov/pubmed/16197570" target="_blank">16197570</a>; DOI:&nbsp;<a href="http://dx.doi.org/10.1079/BJN20051544" target="_blank">10.1079/BJN20051544</a>.

</div><br><div id="R99">99.

Müller&nbsp;K, Haahr&nbsp;PM, Diamant&nbsp;M, Rieneck&nbsp;K, Kharazmi&nbsp;A, Bendtzen&nbsp;K.

<article-title xmlns:oasis="http://docs.oasis-open.org/ns/oasis-exchange/table">1,25-Dihydroxyvitamin D3 inhibits cytokine production by human blood monocytes at the post-transcriptional level</article-title>.

Cytokine&nbsp;1992;

4:506-12; PMID:&nbsp;<a href="http://www.ncbi.nlm.nih.gov/pubmed/1337987" target="_blank">1337987</a>; DOI:&nbsp;<a href="http://dx.doi.org/10.1016/1043-4666(92)90012-G" target="_blank">10.1016/1043-4666(92)90012-G</a>.

</div><br><div id="R100">100.

Schleithoff&nbsp;SS, Zittermann&nbsp;A, Tenderich&nbsp;G, Berthold&nbsp;HK, Stehle&nbsp;P, Koerfer&nbsp;R.

<article-title xmlns:oasis="http://docs.oasis-open.org/ns/oasis-exchange/table">Vitamin D supplementation improves cytokine profiles in patients with congestive heart failure: a double-blind, randomized, placebo-controlled trial</article-title>.

Am J Clin Nutr&nbsp;2006;

83:731-2; PMID:&nbsp;<a href="http://www.ncbi.nlm.nih.gov/pubmed/16600920" target="_blank">16600920</a>.

</div><br><div id="R101">101.

Canning&nbsp;MO, Grotenhuis&nbsp;K, de Wit&nbsp;H, Ruwhof&nbsp;C, Drexhage&nbsp;HA.

<article-title xmlns:oasis="http://docs.oasis-open.org/ns/oasis-exchange/table">1-alpha,25-Dihydroxyvitamin D3 (1,25(OH)(2)D(3)) hampers the maturation of fully active immature dendritic cells from monocytes</article-title>.

Eur J Endocrinol&nbsp;2001;

145:351-7; PMID:&nbsp;<a href="http://www.ncbi.nlm.nih.gov/pubmed/11517017" target="_blank">11517017</a>; DOI:&nbsp;<a href="http://dx.doi.org/10.1530/eje.0.1450351" target="_blank">10.1530/eje.0.1450351</a>.

</div><br><div id="R102">102.

Peterson&nbsp;CA, Heffernan&nbsp;ME.

<article-title xmlns:oasis="http://docs.oasis-open.org/ns/oasis-exchange/table">Serum tumor necrosis factor-alpha concentrations are negatively correlated with serum 25(OH)D concentrations in healthy women</article-title>.

J Inflamm (Lond)&nbsp;2008;

5:10; PMID:&nbsp;<a href="http://www.ncbi.nlm.nih.gov/pubmed/18652680" target="_blank">18652680</a>; DOI:&nbsp;<a href="http://dx.doi.org/10.1186/1476-9255-5-10" target="_blank">10.1186/1476-9255-5-10</a>.

</div><br><div id="R103">103.

Martinesi&nbsp;M, Bruni&nbsp;S, Stio&nbsp;M, Treves&nbsp;C.

<article-title xmlns:oasis="http://docs.oasis-open.org/ns/oasis-exchange/table">1,25-Dihydroxyvitamin D3 inhibits tumor necrosis factor-alpha-induced adhesion molecule expression in endothelial cells</article-title>.

Cell Biol Int&nbsp;2006;

30:365-75; PMID:&nbsp;<a href="http://www.ncbi.nlm.nih.gov/pubmed/16549374" target="_blank">16549374</a>; DOI:&nbsp;<a href="http://dx.doi.org/10.1016/j.cellbi.2006.01.004" target="_blank">10.1016/j.cellbi.2006.01.004</a>.

</div><br><div id="R104">104.

Oh&nbsp;J, Weng&nbsp;S, Felton&nbsp;SK, Bhandare&nbsp;S, Riek&nbsp;A, Butler&nbsp;B, et al.

<article-title xmlns:oasis="http://docs.oasis-open.org/ns/oasis-exchange/table">1,25(OH)2 vitamin d inhibits foam cell formation and suppresses macrophage cholesterol uptake in patients with type 2 diabetes mellitus</article-title>.

Circulation&nbsp;2009;

120:687-98; PMID:&nbsp;<a href="http://www.ncbi.nlm.nih.gov/pubmed/19667238" target="_blank">19667238</a>; DOI:&nbsp;<a href="http://dx.doi.org/10.1161/CIRCULATIONAHA.109.856070" target="_blank">10.1161/CIRCULATIONAHA.109.856070</a>.

</div><br><div id="R105">105.

Riek&nbsp;AE, Oh&nbsp;J, Bernal-Mizrachi&nbsp;C.

<article-title xmlns:oasis="http://docs.oasis-open.org/ns/oasis-exchange/table">Vitamin D regulates macrophage cholesterol metabolism in diabetes</article-title>.

J Steroid Biochem Mol Biol&nbsp;2010;

121:430-3; PMID:&nbsp;<a href="http://www.ncbi.nlm.nih.gov/pubmed/20338238" target="_blank">20338238</a>; DOI:&nbsp;<a href="http://dx.doi.org/10.1016/j.jsbmb.2010.03.018" target="_blank">10.1016/j.jsbmb.2010.03.018</a>.

</div><br><div id="R106">106.

Yiu&nbsp;YF, Chan&nbsp;YH, Yiu&nbsp;KH, Siu&nbsp;CW, Li&nbsp;SW, Wong&nbsp;LY, et al.

<article-title xmlns:oasis="http://docs.oasis-open.org/ns/oasis-exchange/table">Vitamin D deficiency is associated with depletion of circulating endothelial progenitor cells and endothelial dysfunction in patients with type 2 diabetes</article-title>.

J Clin Endocrinol Metab&nbsp;2011;

96:E830-5; PMID:&nbsp;<a href="http://www.ncbi.nlm.nih.gov/pubmed/21325459" target="_blank">21325459</a>; DOI:&nbsp;<a href="http://dx.doi.org/10.1210/jc.2010-2212" target="_blank">10.1210/jc.2010-2212</a>.

</div><br><div id="R107">107.

Rockett&nbsp;KA, Brookes&nbsp;R, Udalova&nbsp;I, Vidal&nbsp;V, Hill&nbsp;AV, Kwiatkowski&nbsp;D.

<article-title xmlns:oasis="http://docs.oasis-open.org/ns/oasis-exchange/table">1,25-Dihydroxyvitamin D3 induces nitric oxide synthase and suppresses growth of Mycobacterium tuberculosis in a human macrophage-like cell line</article-title>.

Infect Immun&nbsp;1998;

66:5314-21; PMID:&nbsp;<a href="http://www.ncbi.nlm.nih.gov/pubmed/9784538" target="_blank">9784538</a>.

</div><br><div id="R108">108.

Willems&nbsp;HM, van den Heuvel&nbsp;EG, Carmeliet&nbsp;G, Schaafsma&nbsp;A, Klein-Nulend&nbsp;J, Bakker&nbsp;AD.

<article-title xmlns:oasis="http://docs.oasis-open.org/ns/oasis-exchange/table">VDR dependent and independent effects of 1,25-dihydroxyvitamin D3 on nitric oxide production by osteoblasts</article-title>.

Steroids&nbsp;2012;

77:126-31; PMID:&nbsp;<a href="http://www.ncbi.nlm.nih.gov/pubmed/22093484" target="_blank">22093484</a>; DOI:&nbsp;<a href="http://dx.doi.org/10.1016/j.steroids.2011.10.015" target="_blank">10.1016/j.steroids.2011.10.015</a>.

</div><br><div id="R109">109.

Molinari&nbsp;C, Uberti&nbsp;F, Grossini&nbsp;E, Vacca&nbsp;G, Carda&nbsp;S, Invernizzi&nbsp;M, et al.

<article-title xmlns:oasis="http://docs.oasis-open.org/ns/oasis-exchange/table">1?,25-dihydroxycholecalciferol induces nitric oxide production in cultured endothelial cells</article-title>.

Cell Physiol Biochem&nbsp;2011;

27:661-8; PMID:&nbsp;<a href="http://www.ncbi.nlm.nih.gov/pubmed/21691084" target="_blank">21691084</a>; DOI:&nbsp;<a href="http://dx.doi.org/10.1159/000330075" target="_blank">10.1159/000330075</a>.

</div><br><div id="R110">110.

Tare&nbsp;M, Emmett&nbsp;SJ, Coleman&nbsp;HA, Skordilis&nbsp;C, Eyles&nbsp;DW, Morley&nbsp;R, et al.

<article-title xmlns:oasis="http://docs.oasis-open.org/ns/oasis-exchange/table">Vitamin D insufficiency is associated with impaired vascular endothelial and smooth muscle function and hypertension in young rats</article-title>.

J Physiol&nbsp;2011;

589:4777-86; PMID:&nbsp;<a href="http://www.ncbi.nlm.nih.gov/pubmed/21807617" target="_blank">21807617</a>; DOI:&nbsp;<a href="http://dx.doi.org/10.1113/jphysiol.2011.214726" target="_blank">10.1113/jphysiol.2011.214726</a>.

</div><br><div id="R111">111.

Chua&nbsp;GT, Chan&nbsp;YC, Cheng&nbsp;SW.

<article-title xmlns:oasis="http://docs.oasis-open.org/ns/oasis-exchange/table">Vitamin D status and peripheral arterial disease: evidence so far</article-title>.

Vasc Health Risk Manag&nbsp;2011;

7:671-5; PMID:&nbsp;<a href="http://www.ncbi.nlm.nih.gov/pubmed/22140318" target="_blank">22140318</a>.

</div><br><div id="R112">112.

Stach&nbsp;K, Kälsch&nbsp;AI, Nguyen&nbsp;XD, Elmas&nbsp;E, Kralev&nbsp;S, Lang&nbsp;S, et al.

<article-title xmlns:oasis="http://docs.oasis-open.org/ns/oasis-exchange/table">1?,25-dihydroxyvitamin D3 attenuates platelet activation and the expression of VCAM-1 and MT1-MMP in human endothelial cells</article-title>.

Cardiology&nbsp;2011;

118:107-15; PMID:&nbsp;<a href="http://www.ncbi.nlm.nih.gov/pubmed/21546774" target="_blank">21546774</a>; DOI:&nbsp;<a href="http://dx.doi.org/10.1159/000327547" target="_blank">10.1159/000327547</a>.

</div><br><div id="R113">113.

Nathan Seppa, Science News December 17, 2011, reporting on AHA Scientific sessions: Arnson Y, Amital H, Mosseri M. Short-term vitamin D inhibits the increase in inflammatory cytokine and adhesion molecule levels in patients after a coronary event. Abstract # 11373. American Heart Association Scientific Sessions, November 12, 2011, Orlando, Fla.</div><br><div id="R114">114.

Chen&nbsp;S, Law&nbsp;CS, Gardner&nbsp;DG.

<article-title xmlns:oasis="http://docs.oasis-open.org/ns/oasis-exchange/table">Vitamin D-dependent suppression of endothelin-induced vascular smooth muscle cell proliferation through inhibition of cdk2 activity</article-title>.

J Steroid Biochem Mol Biol&nbsp;2010;

122:326-32; PMID:&nbsp;<a href="http://www.ncbi.nlm.nih.gov/pubmed/20813185" target="_blank">20813185</a>; DOI:&nbsp;<a href="http://dx.doi.org/10.1016/j.jsbmb.2010.08.007" target="_blank">10.1016/j.jsbmb.2010.08.007</a>.

</div><br><div id="R115">115.

Somjen&nbsp;D, Weisman&nbsp;Y, Kohen&nbsp;F, Gayer&nbsp;B, Limor&nbsp;R, Sharon&nbsp;O, et al.

<article-title xmlns:oasis="http://docs.oasis-open.org/ns/oasis-exchange/table">25-hydroxyvitamin D3-1?-hydroxylase is expressed in human vascular smooth muscle cells and is upregulated by parathyroid hormone and estrogenic compounds</article-title>.

Circulation&nbsp;2005;

111:1666-71; PMID:&nbsp;<a href="http://www.ncbi.nlm.nih.gov/pubmed/15795327" target="_blank">15795327</a>; DOI:&nbsp;<a href="http://dx.doi.org/10.1161/01.CIR.0000160353.27927.70" target="_blank">10.1161/01.CIR.0000160353.27927.70</a>.

</div><br><div id="R116">116.

Laumann&nbsp;EO, West&nbsp;S, Glasser&nbsp;D, Carson&nbsp;C, Rosen&nbsp;R, Kang&nbsp;JH.

<article-title xmlns:oasis="http://docs.oasis-open.org/ns/oasis-exchange/table">Prevalence and correlates of erectile dysfunction by race and ethnicity among men aged 40 or older in the United States: from the male attitudes regarding sexual health survey</article-title>.

J Sex Med&nbsp;2007;

4:57-65; PMID:&nbsp;<a href="http://www.ncbi.nlm.nih.gov/pubmed/17081223" target="_blank">17081223</a>; DOI:&nbsp;<a href="http://dx.doi.org/10.1111/j.1743-6109.2006.00340.x" target="_blank">10.1111/j.1743-6109.2006.00340.x</a>.

</div><br><div id="R117">117.

Kupelian&nbsp;V, Link&nbsp;CL, Rosen&nbsp;RC, McKinlay&nbsp;JB.

<article-title xmlns:oasis="http://docs.oasis-open.org/ns/oasis-exchange/table">Socioeconomic status, not race/ethnicity, contributes to variation in the prevalence of erectile dysfunction: results from the Boston Area Community Health (BACH) Survey</article-title>.

J Sex Med&nbsp;2008;

5:1325-33; PMID:&nbsp;<a href="http://www.ncbi.nlm.nih.gov/pubmed/18410305" target="_blank">18410305</a>; DOI:&nbsp;<a href="http://dx.doi.org/10.1111/j.1743-6109.2008.00822.x" target="_blank">10.1111/j.1743-6109.2008.00822.x</a>.

</div><br><div id="R118">118.

Zeiss&nbsp;AM, Davies&nbsp;HD, Wood&nbsp;M, Tinklenberg&nbsp;JR.

<article-title xmlns:oasis="http://docs.oasis-open.org/ns/oasis-exchange/table">The incidence and correlates of erectile problems in patients with Alzheimer’s disease</article-title>.

Arch Sex Behav&nbsp;1990;

19:325-31; PMID:&nbsp;<a href="http://www.ncbi.nlm.nih.gov/pubmed/2400296" target="_blank">2400296</a>; DOI:&nbsp;<a href="http://dx.doi.org/10.1007/BF01541927" target="_blank">10.1007/BF01541927</a>.

</div><br><div id="R119">119.

Grant&nbsp;WB.

<article-title xmlns:oasis="http://docs.oasis-open.org/ns/oasis-exchange/table">Does vitamin D reduce the risk of dementia?</article-title>.

J Alzheimers Dis&nbsp;2009;

17:151-9; PMID:&nbsp;<a href="http://www.ncbi.nlm.nih.gov/pubmed/19494440" target="_blank">19494440</a>.

</div><br><div id="R120">120.

Chou&nbsp;KT, Huang&nbsp;CC, Chen&nbsp;YM, Perng&nbsp;DW, Chao&nbsp;HS, Chan&nbsp;WL, et al.

<article-title xmlns:oasis="http://docs.oasis-open.org/ns/oasis-exchange/table">Asthma and risk of erectile dysfunction--a nationwide population-based study</article-title>.

J Sex Med&nbsp;2011;

8:1754-60; PMID:&nbsp;<a href="http://www.ncbi.nlm.nih.gov/pubmed/21426497" target="_blank">21426497</a>; DOI:&nbsp;<a href="http://dx.doi.org/10.1111/j.1743-6109.2011.02242.x" target="_blank">10.1111/j.1743-6109.2011.02242.x</a>.

</div><br><div id="R121">121.

Bozzetto&nbsp;S, Carraro&nbsp;S, Giordano&nbsp;G, Boner&nbsp;A, Baraldi&nbsp;E.

<article-title xmlns:oasis="http://docs.oasis-open.org/ns/oasis-exchange/table">Asthma, allergy and respiratory infections: the vitamin D hypothesis</article-title>.

Allergy&nbsp;2012;

67:10-7; PMID:&nbsp;<a href="http://www.ncbi.nlm.nih.gov/pubmed/21933195" target="_blank">21933195</a>; DOI:&nbsp;<a href="http://dx.doi.org/10.1111/j.1398-9995.2011.02711.x" target="_blank">10.1111/j.1398-9995.2011.02711.x</a>.

</div><br><div id="R122">122.

Malekmakan&nbsp;L, Shakeri&nbsp;S, Haghpanah&nbsp;S, Pakfetrat&nbsp;M, Sarvestani&nbsp;AS, Malekmakan&nbsp;A.

<article-title xmlns:oasis="http://docs.oasis-open.org/ns/oasis-exchange/table">Epidemiology of erectile dysfunction in hemodialysis patients using IIEF questionnaire</article-title>.

Saudi J Kidney Dis Transpl&nbsp;2011;

22:232-6; PMID:&nbsp;<a href="http://www.ncbi.nlm.nih.gov/pubmed/21422619" target="_blank">21422619</a>.

</div><br><div id="R123">123.

Kim&nbsp;HS, Chung&nbsp;W, Kim&nbsp;S.

<article-title xmlns:oasis="http://docs.oasis-open.org/ns/oasis-exchange/table">Vitamin d, and kidney disease</article-title>.

Electrolyte Blood Press&nbsp;2011;

9:1-6; PMID:&nbsp;<a href="http://www.ncbi.nlm.nih.gov/pubmed/21998600" target="_blank">21998600</a>; DOI:&nbsp;<a href="http://dx.doi.org/10.5049/EBP.2011.9.1.1" target="_blank">10.5049/EBP.2011.9.1.1</a>.

</div><br><div id="R124">124.

Pilz&nbsp;S, Iodice&nbsp;S, Zittermann&nbsp;A, Grant&nbsp;WB, Gandini&nbsp;S.

<article-title xmlns:oasis="http://docs.oasis-open.org/ns/oasis-exchange/table">Vitamin D status and mortality risk in CKD: a meta-analysis of prospective studies</article-title>.

Am J Kidney Dis&nbsp;2011;

58:374-82; PMID:&nbsp;<a href="http://www.ncbi.nlm.nih.gov/pubmed/21636193" target="_blank">21636193</a>.

</div><br><div id="R125">125.

Perelman&nbsp;MA.

<article-title xmlns:oasis="http://docs.oasis-open.org/ns/oasis-exchange/table">Erectile dysfunction and depression: screening and treatment</article-title>.

Urol Clin North Am&nbsp;2011;

38:125-39; PMID:&nbsp;<a href="http://www.ncbi.nlm.nih.gov/pubmed/21621079" target="_blank">21621079</a>; DOI:&nbsp;<a href="http://dx.doi.org/10.1016/j.ucl.2011.03.004" target="_blank">10.1016/j.ucl.2011.03.004</a>.

</div><br><div id="R126">126.

Hoang&nbsp;MT, Defina&nbsp;LF, Willis&nbsp;BL, Leonard&nbsp;DS, Weiner&nbsp;MF, Brown&nbsp;ES.

<article-title xmlns:oasis="http://docs.oasis-open.org/ns/oasis-exchange/table">Association between low serum 25-hydroxyvitamin D and depression in a large sample of healthy adults: the Cooper Center longitudinal study</article-title>.

Mayo Clin Proc&nbsp;2011;

86:1050-5; PMID:&nbsp;<a href="http://www.ncbi.nlm.nih.gov/pubmed/22033249" target="_blank">22033249</a>; DOI:&nbsp;<a href="http://dx.doi.org/10.4065/mcp.2011.0208" target="_blank">10.4065/mcp.2011.0208</a>.

</div><br><div id="R127">127.

Frost&nbsp;M, Abrahamsen&nbsp;B, Masud&nbsp;T, Brixen&nbsp;K.

<article-title xmlns:oasis="http://docs.oasis-open.org/ns/oasis-exchange/table">Risk factors for fracture in elderly men: a population-based prospective study</article-title>.

Osteoporos Int&nbsp;2012;

23:521-31; PMID:&nbsp;<a href="http://www.ncbi.nlm.nih.gov/pubmed/21409435" target="_blank">21409435</a>; DOI:&nbsp;<a href="http://dx.doi.org/10.1007/s00198-011-1575-4" target="_blank">10.1007/s00198-011-1575-4</a>.

</div><br><div id="R128">128.

Bischoff-Ferrari&nbsp;HA, Willett&nbsp;WC, Wong&nbsp;JB, Giovannucci&nbsp;E, Dietrich&nbsp;T, Dawson-Hughes&nbsp;B.

<article-title xmlns:oasis="http://docs.oasis-open.org/ns/oasis-exchange/table">Fracture prevention with vitamin D supplementation: a meta-analysis of randomized controlled trials</article-title>.

JAMA&nbsp;2005;

293:2257-64; PMID:&nbsp;<a href="http://www.ncbi.nlm.nih.gov/pubmed/15886381" target="_blank">15886381</a>; DOI:&nbsp;<a href="http://dx.doi.org/10.1001/jama.293.18.2257" target="_blank">10.1001/jama.293.18.2257</a>.

</div><br><div id="R129">129.

Lee&nbsp;RK, Chughtai&nbsp;B, Te&nbsp;AE, Kaplan&nbsp;SA.

<article-title xmlns:oasis="http://docs.oasis-open.org/ns/oasis-exchange/table">Sexual function in men with metabolic syndrome</article-title>.

Urol Clin North Am&nbsp;2012;

39:53-62; PMID:&nbsp;<a href="http://www.ncbi.nlm.nih.gov/pubmed/22118345" target="_blank">22118345</a>; DOI:&nbsp;<a href="http://dx.doi.org/10.1016/j.ucl.2011.09.008" target="_blank">10.1016/j.ucl.2011.09.008</a>.

</div><br><div id="R130">130.

Al-Daghri&nbsp;NM, Alkharfy&nbsp;KM, Al-Saleh&nbsp;Y, Al-Attas&nbsp;OS, Alokail&nbsp;MS, Al-Othman&nbsp;A, et al.

<article-title xmlns:oasis="http://docs.oasis-open.org/ns/oasis-exchange/table">Modest reversal of metabolic syndrome manifestations with vitamin D status correction: a 12-month prospective study</article-title>.

Metabolism&nbsp;2011;

; PMID:&nbsp;<a href="http://www.ncbi.nlm.nih.gov/pubmed/22075268" target="_blank">22075268</a>; DOI:&nbsp;<a href="http://dx.doi.org/10.1016/j.metabol.2011.09.017" target="_blank">10.1016/j.metabol.2011.09.017</a>.

</div><br><div id="R131">131.

Severson B. Sexual Dysfunction and Multiple Sclerosis. U.S. Dept. of Veterans Affairs, Multiple Sclerosis Center of Excellence. 2010. Available at http://www.va.gov/MS/articles/Sexual_Dysfunction_and_Multiple_Sclerosis.asp. Accessed Dec 27, 2011.</div><br><div id="R132">132.

Boston Medical Group Online. Multiple Sclerosis and Erectile dysfunction. http://www.multiplesclerosiserectiledysfunction.com/ Accessed December 27, 2011.</div><br><div id="R133">133.

Munger&nbsp;KL, Zhang&nbsp;SM, O’Reilly&nbsp;E, Hernán&nbsp;MA, Olek&nbsp;MJ, Willett&nbsp;WC, et al.

<article-title xmlns:oasis="http://docs.oasis-open.org/ns/oasis-exchange/table">Vitamin D intake and incidence of multiple sclerosis</article-title>.

Neurology&nbsp;2004;

62:60-5; PMID:&nbsp;<a href="http://www.ncbi.nlm.nih.gov/pubmed/14718698" target="_blank">14718698</a>.

</div><br><div id="R134">134.

Mirzaei&nbsp;F, Michels&nbsp;KB, Munger&nbsp;K, O’Reilly&nbsp;E, Chitnis&nbsp;T, Forman&nbsp;MR, et al.

<article-title xmlns:oasis="http://docs.oasis-open.org/ns/oasis-exchange/table">Gestational vitamin D and the risk of multiple sclerosis in offspring</article-title>.

Ann Neurol&nbsp;2011;

70:30-40; PMID:&nbsp;<a href="http://www.ncbi.nlm.nih.gov/pubmed/21786297" target="_blank">21786297</a>; DOI:&nbsp;<a href="http://dx.doi.org/10.1002/ana.22456" target="_blank">10.1002/ana.22456</a>.

</div><br><div id="R135">135.

Chao&nbsp;JK, Hwang&nbsp;TI, Ma&nbsp;MC, Kuo&nbsp;WH, Liu&nbsp;JH, Chen&nbsp;YP, et al.

<article-title xmlns:oasis="http://docs.oasis-open.org/ns/oasis-exchange/table">A survey of obesity and erectile dysfunction of men conscripted into the military in Taiwan</article-title>.

J Sex Med&nbsp;2011;

8:1156-63; PMID:&nbsp;<a href="http://www.ncbi.nlm.nih.gov/pubmed/21269394" target="_blank">21269394</a>; DOI:&nbsp;<a href="http://dx.doi.org/10.1111/j.1743-6109.2010.02181.x" target="_blank">10.1111/j.1743-6109.2010.02181.x</a>.

</div><br><div id="R136">136.

Earthman&nbsp;CP, Beckman&nbsp;LM, Masodkar&nbsp;K, Sibley&nbsp;SD.

<article-title xmlns:oasis="http://docs.oasis-open.org/ns/oasis-exchange/table">The link between obesity and low circulating 25-hydroxyvitamin D concentrations: considerations and implications</article-title>.

Int J Obes (Lond)&nbsp;2012;

36:387-96; PMID:&nbsp;<a href="http://www.ncbi.nlm.nih.gov/pubmed/21694701" target="_blank">21694701</a>; DOI:&nbsp;<a href="http://dx.doi.org/10.1038/ijo.2011.119" target="_blank">10.1038/ijo.2011.119</a>.

</div><br><div id="R137">137.

Roumiguié&nbsp;M, Guillotreau&nbsp;J, Castel-Lacanal&nbsp;E, Malavaud&nbsp;B, De Boissezon&nbsp;X, Marque&nbsp;P, et al.

<article-title xmlns:oasis="http://docs.oasis-open.org/ns/oasis-exchange/table">[Assessment of sexual function in men with idiopathic Parkinson’s disease using the International Index of Erectile Dysfunction (IIEF-15)]</article-title>.

Prog Urol&nbsp;2011;

21:67-71; PMID:&nbsp;<a href="http://www.ncbi.nlm.nih.gov/pubmed/21193148" target="_blank">21193148</a>.

</div><br><div id="R138">138.

Evatt&nbsp;ML, DeLong&nbsp;MR, Kumari&nbsp;M, Auinger&nbsp;P, McDermott&nbsp;MP, Tangpricha&nbsp;V.

<article-title xmlns:oasis="http://docs.oasis-open.org/ns/oasis-exchange/table">High prevalence of hypovitaminosis D status in patients with early Parkinson disease</article-title>.

Arch Neurol&nbsp;2011;

68:314-9; PMID:&nbsp;<a href="http://www.ncbi.nlm.nih.gov/pubmed/21403017" target="_blank">21403017</a>; DOI:&nbsp;<a href="http://dx.doi.org/10.1001/archneurol.2011.30" target="_blank">10.1001/archneurol.2011.30</a>.

</div><br><div id="R139">139.

Zadik&nbsp;Y, Bechor&nbsp;R, Galor&nbsp;S, Justo&nbsp;D, Heruti&nbsp;RJ.

<article-title xmlns:oasis="http://docs.oasis-open.org/ns/oasis-exchange/table">Erectile dysfunction might be associated with chronic periodontal disease: two ends of the cardiovascular spectrum</article-title>.

J Sex Med&nbsp;2009;

6:1111-6; PMID:&nbsp;<a href="http://www.ncbi.nlm.nih.gov/pubmed/19170861" target="_blank">19170861</a>; DOI:&nbsp;<a href="http://dx.doi.org/10.1111/j.1743-6109.2008.01141.x" target="_blank">10.1111/j.1743-6109.2008.01141.x</a>.

</div><br><div id="R140">140.

Grant&nbsp;WB, Boucher&nbsp;BJ.

<article-title xmlns:oasis="http://docs.oasis-open.org/ns/oasis-exchange/table">Are Hill’s criteria for causality satisfied for vitamin D and periodontal disease<i>?</i></article-title>.

Dermatoendocrinol&nbsp;2010;

2:30-6; PMID:&nbsp;<a href="http://www.ncbi.nlm.nih.gov/pubmed/21547146" target="_blank">21547146</a>; DOI:&nbsp;<a href="http://dx.doi.org/10.4161/derm.2.1.12488" target="_blank">10.4161/derm.2.1.12488</a>.

</div><br><div id="R141">141.

Chung&nbsp;SD, Keller&nbsp;JJ, Chu&nbsp;TW, Lin&nbsp;HC.

<article-title xmlns:oasis="http://docs.oasis-open.org/ns/oasis-exchange/table">Psoriasis and the risk of erectile dysfunction: a population-based case-control study</article-title>.

J Sex Med&nbsp;2012;

9:130-5; PMID:&nbsp;<a href="http://www.ncbi.nlm.nih.gov/pubmed/22023713" target="_blank">22023713</a>; DOI:&nbsp;<a href="http://dx.doi.org/10.1111/j.1743-6109.2011.02510.x" target="_blank">10.1111/j.1743-6109.2011.02510.x</a>.

</div><br><div id="R142">142.

Rácz&nbsp;E, Prens&nbsp;EP, Kurek&nbsp;D, Kant&nbsp;M, de Ridder&nbsp;D, Mourits&nbsp;S, et al.

<article-title xmlns:oasis="http://docs.oasis-open.org/ns/oasis-exchange/table">Effective treatment of psoriasis with narrow-band UVB phototherapy is linked to suppression of the IFN and Th17 pathways</article-title>.

J Invest Dermatol&nbsp;2011;

131:1547-58; PMID:&nbsp;<a href="http://www.ncbi.nlm.nih.gov/pubmed/21412260" target="_blank">21412260</a>; DOI:&nbsp;<a href="http://dx.doi.org/10.1038/jid.2011.53" target="_blank">10.1038/jid.2011.53</a>.

</div><br><div id="R143">143.

Safarinejad&nbsp;MR.

<article-title xmlns:oasis="http://docs.oasis-open.org/ns/oasis-exchange/table">Prevalence and risk factors for erectile dysfunction in a population-based study in Iran</article-title>.

Int J Impot Res&nbsp;2003;

15:246-52; PMID:&nbsp;<a href="http://www.ncbi.nlm.nih.gov/pubmed/12934051" target="_blank">12934051</a>; DOI:&nbsp;<a href="http://dx.doi.org/10.1038/sj.ijir.3901024" target="_blank">10.1038/sj.ijir.3901024</a>.

</div><br><div id="R144">144.

Brot&nbsp;C, Jorgensen&nbsp;NR, Sorensen&nbsp;OH.

<article-title xmlns:oasis="http://docs.oasis-open.org/ns/oasis-exchange/table">The influence of smoking on vitamin D status and calcium metabolism</article-title>.

Eur J Clin Nutr&nbsp;1999;

53:920-6; PMID:&nbsp;<a href="http://www.ncbi.nlm.nih.gov/pubmed/10602348" target="_blank">10602348</a>; DOI:&nbsp;<a href="http://dx.doi.org/10.1038/sj.ejcn.1600870" target="_blank">10.1038/sj.ejcn.1600870</a>.

</div><br><div id="R145">145.

Chung&nbsp;SD, Keller&nbsp;JJ, Lin&nbsp;HC.

<article-title xmlns:oasis="http://docs.oasis-open.org/ns/oasis-exchange/table">Association of erectile dysfunction with atopic dermatitis: a population-based case-control study</article-title>.

J Sex Med&nbsp;2012;

9:679-85; PMID:&nbsp;<a href="http://www.ncbi.nlm.nih.gov/pubmed/22240253" target="_blank">22240253</a>; DOI:&nbsp;<a href="http://dx.doi.org/10.1111/j.1743-6109.2011.02587.x" target="_blank">10.1111/j.1743-6109.2011.02587.x</a>.

</div><br><div id="R146">146.

Amestejani&nbsp;M, Salehi&nbsp;BS, Vasigh&nbsp;M, Sobhkhiz&nbsp;A, Karami&nbsp;M, Alinia&nbsp;H, et al.

<article-title xmlns:oasis="http://docs.oasis-open.org/ns/oasis-exchange/table">Vitamin d supplementation in the treatment of atopic dermatitis: a clinical trial study</article-title>.

J Drugs Dermatol&nbsp;2012;

11:327-30; PMID:&nbsp;<a href="http://www.ncbi.nlm.nih.gov/pubmed/22395583" target="_blank">22395583</a>.

</div><br><div id="R147">147.

Drugs.com. Viagra Side Effects. http://www.drugs.com/sfx/viagra-side-effects.html. Accessed Dec. 20, 2011.</div><br></div><img src="./dertmato 7_files/delete.png" style="display:inline;" role=".license"><h4 class="section_title" style="font-weight: bold; color: rgb(101, 77, 62); ">License</h4><br><br><div class="license"><a rel="license" href="http://creativecommons.org/licenses/by-nc/3.0/"><img alt="Creative Commons License" style="border-width:0;" src="./dertmato 7_files/88x31.png"></a><br>This is an Open Access article licensed under a <a rel="license" href="http://creativecommons.org/licenses/by-nc/3.0/">Creative Commons Attribution-NonCommercial 3.0 Unported License</a>. The article may be redistributed, reproduced and reused for non-commercial purposes, provided the original source is properly cited.

</div></div><div id="step_top" class="top_return" style="cursor: pointer; color: rgb(128, 64, 0); font-weight: bold; display: none; ">

<div style="padding:10px 0 10px 0">Top</div>

</div><div id="step_back" class="top_return" style="top: 80px; left: 20px; cursor: pointer; color: rgb(128, 64, 0); font-weight: bold; ">

<div style="padding:10px 0 10px 0">Back</div>

</div><div id="section_jump" class="top_return" style="top:140px;display:inline;height:auto;width:auto;">

<table style="margin-top:20px;">

<tbody><tr>

<td style="border-right-width: 6px; border-right-style: double; border-right-color: rgb(221, 221, 221); display: none; ">

<ul style="white-space:nowrap;padding-right:40px;">

<li style="padding-top: 5px; padding-right: 5px; padding-bottom: 5px; padding-left: 5px; cursor: pointer; color: rgb(128, 64, 0); "><img src="./dertmato 7_files/delete.png" style="display:inline;" role=".section_1">Introduction: Important facts pertaining to this discussion</li>

<li style="padding-top: 5px; padding-right: 5px; padding-bottom: 5px; padding-left: 5px; cursor: pointer; color: rgb(128, 64, 0); "><img src="./dertmato 7_files/delete.png" style="display:inline;" role=".section_2">The role of vascular disorders in ED</li>

<li style="padding-top: 5px; padding-right: 5px; padding-bottom: 5px; padding-left: 5px; cursor: pointer; color: rgb(128, 64, 0); "><img src="./dertmato 7_files/delete.png" style="display:inline;" role=".section_3">The role of vitamin D and sunlight on CVD</li>

<li style="padding-top: 5px; padding-right: 5px; padding-bottom: 5px; padding-left: 5px; cursor: pointer; color: rgb(128, 64, 0); "><img src="./dertmato 7_files/delete.png" style="display:inline;" role=".section_4">Possible influence of sunlight or vitamin D on four major risk factors for CVD and ED</li>

<li style="padding-top: 5px; padding-right: 5px; padding-bottom: 5px; padding-left: 5px; cursor: pointer; color: rgb(128, 64, 0); "><img src="./dertmato 7_files/delete.png" style="display:inline;" role=".section_5">Conclusion</li>

<li style="padding-top: 5px; padding-right: 5px; padding-bottom: 5px; padding-left: 5px; cursor: pointer; color: rgb(128, 64, 0); "><img src="./dertmato 7_files/delete.png" style="display:inline;" role=".references">References</li>

<li style="padding-top: 5px; padding-right: 5px; padding-bottom: 5px; padding-left: 5px; cursor: pointer; color: rgb(128, 64, 0); "><img src="./dertmato 7_files/delete.png" style="display:inline;" role=".license">License</li>

</ul>

</td>

<td id="jump_button" style="vertical-align: top; width: 65px; text-align: center; cursor: pointer; color: rgb(128, 64, 0); font-weight: bold; ">

<div id="jump_text">Jump to Section</div>

</td>

</tr>

</tbody></table>

</div>

<hr class="space">

</div>

</div>

<div id="landes_content_east" class=" span-4 last prepend-top append-bottom"> 

<span class="small " style="color:#BBB;">Advertisements</span> 

<div id="lbsmod3204" class=" landes_component full_block banner_ad clearfix append-bottom ">

<a href="http://www.ithenticate.com/" onclick="javascript: pageTracker._trackPageview('/bannerads/ithenticate/ithenticate');" target="_blank"><img src="./dertmato 7_files/iThenticate-Button-21.png"></a>

</div> 

<div id="lbsmod3366" class=" landes_component full_block banner_ad clearfix append-bottom ">

<a href="http://itunes.apple.com/us/app/landes-bioscience/id413237470?mt=8&ls=1" onclick="javascript: pageTracker._trackPageview('/bannerads/Landes/ipad App 2.0 AD');" target="_blank"><img src="./dertmato 7_files/ipad2_ad.gif"></a>

</div>

<div id="lbsmod2671" class=" landes_component full_block banner_ad clearfix append-bottom ">

<a href="https://www.landesbioscience.com/journals/rss/" onclick="javascript: pageTracker._trackPageview('/bannerads/Landes/lb-rss');" target="_blank"><img src="./dertmato 7_files/LB-RSS-webAd_2.gif"></a>

</div> 

<div id="lbsmod1943" class=" landes_component full_block banner_ad clearfix append-bottom ">

<a href="https://www.landesbioscience.com/jobs/" onclick="javascript: pageTracker._trackPageview('/bannerads/Landes/job_search');" target="_blank"><img src="./dertmato 7_files/Job-Search.gif"></a>

</div> 

<div id="lbsmod897" class=" landes_component full_block banner_ad clearfix append-bottom ">

<a href="https://www.who.int/hinari/about/en/" onclick="javascript: pageTracker._trackPageview('/bannerads/Landes/HInari');" target="_blank"><img src="./dertmato 7_files/hinari-new.jpg"></a>

</div>    

</div>

</div>

</div>

</div>

<div id="landes_footer" style="height:90px;">

<div style="text-align:center;" class="prepend-top append-bottom clearfix">

<ul id="landes_footer_nav" class="clearfix ">

<li><a href="http://www.landesbioscience.com/contact/">Contact Us</a></li>

<li><a href="http://www.landesbioscience.com/user_agreement/">Terms and Agreement</a></li>

<li><a href="mailto:info@landesbioscience.com">Feedback</a></li>

<li><a href="http://www.landesbioscience.com/journals/advertising/">Advertising</a></li>

<li><span>You are accessing our site from 71.212.110.83</span></li>

</ul>

</div>

<div style="height:20px;" class="append-bottom clearfix">

<ul id="landes_footer_list" class="clearfix">

<li>© Landes Bioscience</li>

<li>1806 Rio Grande St., Austin, TX 78701</li>

<li>ph: 512.637.6050</li>

<li>fax: 512.637.6079</li>

</ul>

</div>

</div>

<script type="text/javascript">if(!NREUMQ.f){NREUMQ.f=function(){NREUMQ.push(["load",new Date().getTime()]);var e=document.createElement("script");e.type="text/javascript";e.async=true;e.src="https://d1ros97qkrwjf5.cloudfront.net/30/eum/rum.js";document.body.appendChild(e);if(NREUMQ.a)NREUMQ.a();};NREUMQ.a=window.onload;window.onload=NREUMQ.f;};NREUMQ.push(["nrf2","beacon-1.newrelic.com","ac71ba990c",603060,"ZQNWMkpYXhUHAkZZXFxJYRRRFlkIAgRKHkNaFg==",0,249,new Date().getTime()]);</script>

<script type="text/javascript" async="" src="./dertmato 7_files/rum.js"></script><script id="nreum-send-beacon" type="text/x-nreum-data"></script></body></html>